<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Renal cell carcinoma - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Renal_cell_carcinoma" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Renal_cell_carcinoma" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Renal_cell_carcinoma" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Renal_cell_carcinoma","wgTitle":"Renal cell carcinoma","wgCurRevisionId":668655105,"wgRevisionId":668655105,"wgArticleId":414178,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages with DOIs inactive since 2015","CS1 French-language sources (fr)","All articles with dead external links","Articles with dead external links from December 2013","Articles with contributors link","Articles that use a Medicine navs subtemplate","Kidney cancer"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Renal_cell_carcinoma","wgRelevantArticleId":414178,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clear_cell_renal_cell_carcinoma_high_mag.jpg/100px-Clear_cell_renal_cell_carcinoma_high_mag.jpg","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q1164529"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Renal_cell_carcinoma skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Renal cell carcinoma</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="hatnote">For other uses, see <a href="/wiki/RCC_(disambiguation)" title="RCC (disambiguation)" class="mw-redirect">RCC (disambiguation)</a>.</div>
<table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Renal cell carcinoma</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Clear_cell_renal_cell_carcinoma_high_mag.jpg" class="image"><img alt="Clear cell renal cell carcinoma high mag.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clear_cell_renal_cell_carcinoma_high_mag.jpg/230px-Clear_cell_renal_cell_carcinoma_high_mag.jpg" width="230" height="153" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clear_cell_renal_cell_carcinoma_high_mag.jpg/345px-Clear_cell_renal_cell_carcinoma_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/32/Clear_cell_renal_cell_carcinoma_high_mag.jpg/460px-Clear_cell_renal_cell_carcinoma_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>
<div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of the most common type of <b>renal cell carcinoma</b> (clear cell) - on right of the image; non-tumour kidney is on the left of the image. Nephrectomy specimen. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Oncology" title="Oncology">Oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C64">C64</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=189.0">189.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I83123/">8312/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/144700">144700</a> <a rel="nofollow" class="external text" href="//omim.org/entry/605074">605074</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb11245.htm">11245</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000516.htm">000516</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic2002.htm">med/2002</a></td>
</tr>
</table>
<p><b>Renal cell carcinoma</b> (<b>RCC</b>, also known as <b>hypernephroma</b>, Grawitz tumor, renal adenocarcinoma) is a <a href="/wiki/Kidney_cancer" title="Kidney cancer">kidney cancer</a> that originates in the lining of the <a href="/wiki/Proximal_tubule" title="Proximal tubule" class="mw-redirect">proximal convoluted tubule</a>, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90-95% of cases.<sup id="cite_ref-MSR_1-0" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> Initial treatment is most commonly either partial or complete removal of the affected kidney(s) and remains the mainstay of curative treatment.<sup id="cite_ref-r_2-0" class="reference"><a href="#cite_note-r-2"><span>[</span>2<span>]</span></a></sup> Where the cancer has not metastasised (spread to other organs) or burrowed deeper into the tissues of the kidney the 5-year survival rate is 65-90%,<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> but this is lowered considerably when the cancer has spread. It is relatively resistant to <a href="/wiki/Radiation_therapy" title="Radiation therapy">radiation therapy</a> and <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, although some cases respond to targeted therapies such as <a href="/wiki/Sunitinib" title="Sunitinib">sunitinib</a>, <a href="/wiki/Temsirolimus" title="Temsirolimus">temsirolimus</a>, <a href="/wiki/Bevacizumab" title="Bevacizumab">bevacizumab</a>, <a href="/wiki/Interferon_alfa" title="Interferon alfa">interferon alfa</a> and <a href="/wiki/Sorafenib" title="Sorafenib">sorafenib</a> which have improved the outlook for RCC.<sup id="cite_ref-singer_4-0" class="reference"><a href="#cite_note-singer-4"><span>[</span>4<span>]</span></a></sup></p>
<p>The body is remarkably good at hiding the symptoms and as a result people with RCC often have advanced disease by the time it is discovered.<sup id="cite_ref-path_5-0" class="reference"><a href="#cite_note-path-5"><span>[</span>5<span>]</span></a></sup> The initial symptoms of RCC often include: <a href="/wiki/Haematuria" title="Haematuria" class="mw-redirect">blood in the urine</a> (occurring in 40% of affected persons at the time they first seek medical attention), <a href="/wiki/Flank_pain" title="Flank pain" class="mw-redirect">flank pain</a> (40%), a mass in the abdomen or flank (25%), weight loss (33%), fever (20%), <a href="/wiki/Hypertension" title="Hypertension">high blood pressure</a> (20%), night sweats and <a href="/wiki/Malaise" title="Malaise">generally feeling unwell</a>.<sup id="cite_ref-MSR_1-1" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> RCC is also associated with a number of <a href="/wiki/Paraneoplastic_syndromes" title="Paraneoplastic syndromes" class="mw-redirect">paraneoplastic syndromes</a> (PNS) which are conditions caused by either the hormones produced by the tumour or by the body's attack on the tumour and are present in about 20% of those with RCC.<sup id="cite_ref-MSR_1-2" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> These syndromes most commonly affect tissues which have not been invaded by the cancer.<sup id="cite_ref-MSR_1-3" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> The most common PNSs seen in people with RCC are: <a href="/wiki/Anaemia" title="Anaemia" class="mw-redirect">anaemia</a> (due to an underproduction of the hormone, <a href="/wiki/Erythropoietin" title="Erythropoietin">erythropoietin</a>), <a href="/wiki/Hypercalcaemia" title="Hypercalcaemia">high blood calcium levels</a>, <a href="/wiki/Polycythaemia" title="Polycythaemia" class="mw-redirect">polycythaemia</a> (the opposite to anaemia, due to an overproduction of erythropoietin), <a href="/wiki/Thrombocytosis" title="Thrombocytosis">thrombocytosis</a> (too many platelets in the blood, leading to an increased tendency for blood clots and bleeds) and secondary <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a>.<sup id="cite_ref-MM_6-0" class="reference"><a href="#cite_note-MM-6"><span>[</span>6<span>]</span></a></sup> When RCC metastasises it most commonly spreads to the <a href="/wiki/Lymph_nodes" title="Lymph nodes" class="mw-redirect">lymph nodes</a>, <a href="/wiki/Lungs" title="Lungs" class="mw-redirect">lungs</a>, <a href="/wiki/Liver" title="Liver">liver</a>, <a href="/wiki/Adrenal_glands" title="Adrenal glands" class="mw-redirect">adrenal glands</a>, <a href="/wiki/Brain" title="Brain">brain</a> or bones.<sup id="cite_ref-MM_6-1" class="reference"><a href="#cite_note-MM-6"><span>[</span>6<span>]</span></a></sup></p>
<div class="toclimit-3">
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Cause"><span class="tocnumber">2</span> <span class="toctext">Cause</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Lifestyle"><span class="tocnumber">2.1</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Genetics"><span class="tocnumber">2.2</span> <span class="toctext">Genetics</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-7"><a href="#Classification"><span class="tocnumber">4.1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Laboratory_tests"><span class="tocnumber">4.2</span> <span class="toctext">Laboratory tests</span></a>
<ul>
<li class="toclevel-3 tocsection-9"><a href="#Urine_analysis"><span class="tocnumber">4.2.1</span> <span class="toctext">Urine analysis</span></a></li>
<li class="toclevel-3 tocsection-10"><a href="#Complete_blood_cell_count"><span class="tocnumber">4.2.2</span> <span class="toctext">Complete blood cell count</span></a></li>
<li class="toclevel-3 tocsection-11"><a href="#Blood_chemistry"><span class="tocnumber">4.2.3</span> <span class="toctext">Blood chemistry</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-12"><a href="#Radiology"><span class="tocnumber">4.3</span> <span class="toctext">Radiology</span></a>
<ul>
<li class="toclevel-3 tocsection-13"><a href="#Computed_tomography"><span class="tocnumber">4.3.1</span> <span class="toctext">Computed tomography</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Ultrasound"><span class="tocnumber">4.3.2</span> <span class="toctext">Ultrasound</span></a></li>
<li class="toclevel-3 tocsection-15"><a href="#Magnetic_resonance_imaging"><span class="tocnumber">4.3.3</span> <span class="toctext">Magnetic resonance imaging</span></a></li>
<li class="toclevel-3 tocsection-16"><a href="#Intravenous_pyelogram"><span class="tocnumber">4.3.4</span> <span class="toctext">Intravenous pyelogram</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Renal_angiography"><span class="tocnumber">4.3.5</span> <span class="toctext">Renal angiography</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-18"><a href="#Staging"><span class="tocnumber">4.4</span> <span class="toctext">Staging</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Histopathology"><span class="tocnumber">4.5</span> <span class="toctext">Histopathology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#Management"><span class="tocnumber">5</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-21"><a href="#Active_surveillance"><span class="tocnumber">5.1</span> <span class="toctext">Active surveillance</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Surgery"><span class="tocnumber">5.2</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Targeted_ablative_therapies"><span class="tocnumber">5.3</span> <span class="toctext">Targeted ablative therapies</span></a></li>
<li class="toclevel-2 tocsection-24"><a href="#Targeted_drug_treatments"><span class="tocnumber">5.4</span> <span class="toctext">Targeted drug treatments</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Chemotherapy"><span class="tocnumber">5.5</span> <span class="toctext">Chemotherapy</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Vaccine"><span class="tocnumber">5.6</span> <span class="toctext">Vaccine</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Adjuvant_and_neoadjuvant_therapy"><span class="tocnumber">5.7</span> <span class="toctext">Adjuvant and neoadjuvant therapy</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-28"><a href="#Metastatic_renal_cell_carcinoma"><span class="tocnumber">6</span> <span class="toctext">Metastatic renal cell carcinoma</span></a></li>
<li class="toclevel-1 tocsection-29"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-32"><a href="#Hypernephroma_controversy"><span class="tocnumber">9.1</span> <span class="toctext">Hypernephroma controversy</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-33"><a href="#See_also"><span class="tocnumber">10</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-34"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Historically, medical practitioners expected a person to present with three findings. This classic triad<sup id="cite_ref-cohen_7-0" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> is 1: <a href="/wiki/Haematuria" title="Haematuria" class="mw-redirect">haematuria</a>, which is when there is blood present in the urine, 2: flank pain, which is pain on the side of the body between the hip and ribs, and 3: an abdominal mass, similar to bloating but larger. It is now known that this classic triad of symptoms only occurs in 10-15% of cases, and is usually indicative that the renal cell carcinoma (RCC) in an advanced stage.<sup id="cite_ref-cohen_7-1" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> Today, RCC is often asymptomatic (meaning little to no symptoms) and is generally detected incidentally when a person is being examined for other ailments.<sup id="cite_ref-motzer_8-0" class="reference"><a href="#cite_note-motzer-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Other signs and symptom may include <a href="/wiki/Haematuria" title="Haematuria" class="mw-redirect">haematuria</a>;<sup id="cite_ref-cohen_7-2" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> loin pain;<sup id="cite_ref-cohen_7-3" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> abdominal mass;<sup id="cite_ref-motzer_8-1" class="reference"><a href="#cite_note-motzer-8"><span>[</span>8<span>]</span></a></sup> <a href="/wiki/Malaise" title="Malaise">malaise</a>, which is a general feeling of feeling unwell;<sup id="cite_ref-motzer_8-2" class="reference"><a href="#cite_note-motzer-8"><span>[</span>8<span>]</span></a></sup> weight loss and/or loss of appetite;<sup id="cite_ref-kim_9-0" class="reference"><a href="#cite_note-kim-9"><span>[</span>9<span>]</span></a></sup> <a href="/wiki/Anaemia" title="Anaemia" class="mw-redirect">anaemia</a> resulting from depression of <a href="/wiki/Erythropoietin" title="Erythropoietin">erythropoietin</a>;<sup id="cite_ref-cohen_7-4" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Erythrocytosis" title="Erythrocytosis" class="mw-redirect">erythrocytosis</a> (increased production of <a href="/wiki/Red_blood_cell" title="Red blood cell">red blood cells</a>) due to increased erythropoietin secretion;<sup id="cite_ref-cohen_7-5" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Varicocele" title="Varicocele">varicocele</a>, which is seen in males as an enlargement of the tissue at the testicle (more often the left testicle)<sup id="cite_ref-motzer_8-3" class="reference"><a href="#cite_note-motzer-8"><span>[</span>8<span>]</span></a></sup> <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> (high blood pressure) resulting from secretion of <a href="/wiki/Renin" title="Renin">renin</a> by the tumour;<sup id="cite_ref-Birkhauser2013_10-0" class="reference"><a href="#cite_note-Birkhauser2013-10"><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">hypercalcemia</a>, which is elevation of calcium levels in the blood;<sup id="cite_ref-Lane_11-0" class="reference"><a href="#cite_note-Lane-11"><span>[</span>11<span>]</span></a></sup> sleep disturbance or night sweats;<sup id="cite_ref-kim_9-1" class="reference"><a href="#cite_note-kim-9"><span>[</span>9<span>]</span></a></sup> recurrent <a href="/wiki/Fever" title="Fever">fevers</a>;<sup id="cite_ref-kim_9-2" class="reference"><a href="#cite_note-kim-9"><span>[</span>9<span>]</span></a></sup> and chronic fatigue.<sup id="cite_ref-metz_12-0" class="reference"><a href="#cite_note-metz-12"><span>[</span>12<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=2" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=3" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The greatest risk factors for RCC are lifestyle-related; smoking, obesity and <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> (high blood pressure) have been estimated to account for up to 50% of cases.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> Occupational exposure to some chemicals such as asbestos, cadmium, lead, chlorinated solvents, petrochemicals and PAH (polycyclic aromatic hydrocarbon) has been examined by multiple studies with inconclusive results.<sup id="cite_ref-Ljungberg_et_al_2011_14-0" class="reference"><a href="#cite_note-Ljungberg_et_al_2011-14"><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> Another suspected risk factor is the long term use of <a href="/wiki/Non-steroidal_anti-inflammatory_drugs" title="Non-steroidal anti-inflammatory drugs" class="mw-redirect">non-steroidal anti-inflammatory drugs</a> (NSAIDS).<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup></p>
<p>Finally, studies have found that women who have had a <a href="/wiki/Hysterectomy" title="Hysterectomy">hysterectomy</a> are at more than double the risk of developing RCC than those who have not.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> The reason for this remains unclear.</p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=4" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Hereditary factors have a minor impact on individual susceptibility with immediate relatives of people with RCC having a two to fourfold increased risk of developing the condition.<sup id="cite_ref-Lipworth2009_19-0" class="reference"><a href="#cite_note-Lipworth2009-19"><span>[</span>19<span>]</span></a></sup> Other genetically linked conditions also increase the risk of RCC, including hereditary papillary renal carcinoma, hereditary <a href="/wiki/Leiomyomatosis" title="Leiomyomatosis" class="mw-redirect">leiomyomatosis</a>, <a href="/wiki/Birt-Hogg-Dube_syndrome" title="Birt-Hogg-Dube syndrome" class="mw-redirect">Birt-Hogg-Dube syndrome</a>, hyperparathyroidism-jaw tumor syndrome, familial <a href="/wiki/Papillary_thyroid_carcinoma" title="Papillary thyroid carcinoma" class="mw-redirect">papillary thyroid carcinoma</a>, <a href="/wiki/Von_Hippel-Lindau_disease" title="Von Hippel-Lindau disease" class="mw-redirect">von Hippel-Lindau</a> disease<sup id="cite_ref-Pavlovich2004_20-0" class="reference"><a href="#cite_note-Pavlovich2004-20"><span>[</span>20<span>]</span></a></sup> and <a href="/wiki/Sickle_cell_disease" title="Sickle cell disease" class="mw-redirect">sickle cell disease</a>.<sup id="cite_ref-rini_21-0" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup></p>
<p>The most significant disease affecting risk however is not genetically linked – patients with acquired <a href="/wiki/Cyst" title="Cyst">cystic</a> disease of the kidney requiring dialysis are 30 times greater more likely than the general population to develop RCC.<sup id="cite_ref-Baldewijns2008_22-0" class="reference"><a href="#cite_note-Baldewijns2008-22"><span>[</span>22<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=5" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The tumour arises from the cells of the <a href="/wiki/Proximal_renal_tubule" title="Proximal renal tubule" class="mw-redirect">proximal renal tubular</a> epithelium.<sup id="cite_ref-MSR_1-4" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> It is considered an <a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinoma</a>.<sup id="cite_ref-MM_6-2" class="reference"><a href="#cite_note-MM-6"><span>[</span>6<span>]</span></a></sup> There are two subtypes: sporadic (that is, non-hereditary) and hereditary.<sup id="cite_ref-MSR_1-5" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup> Both such subtypes are associated with mutations in the short-arm of <a href="/wiki/Chromosome_3" title="Chromosome 3" class="mw-redirect">chromosome 3</a>, with the implicated genes being either tumour suppressor genes (<a href="/wiki/Von_Hippel%E2%80%93Lindau_tumor_suppressor" title="Von Hippel–Lindau tumor suppressor">VHL</a> and <a href="/wiki/Tuberous_sclerosis_protein" title="Tuberous sclerosis protein">TSC</a>) or oncogenes (like <a href="/wiki/C-Met" title="C-Met">c-Met</a>).<sup id="cite_ref-MSR_1-6" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=6" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first steps taken to diagnose this condition are consideration of the signs and symptoms, and a <a href="/wiki/Medical_history" title="Medical history">medical history</a> (the detailed medical review of past health state) to evaluate any risk factors. Based on the symptoms presented, a range of <a href="/wiki/Biochemical" title="Biochemical" class="mw-redirect">biochemical</a> tests (using blood and/or urine samples) may also be considered as part of the screening process to provide sufficient quantitative analysis of any differences in <a href="/wiki/Electrolytes" title="Electrolytes" class="mw-redirect">electrolytes</a>, renal and liver function, and blood clotting times.<sup id="cite_ref-rini_21-1" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup> Upon physical examination, palpation of the abdomen may reveal the presence of a mass or an organ enlargement.<sup id="cite_ref-Tjaden_23-0" class="reference"><a href="#cite_note-Tjaden-23"><span>[</span>23<span>]</span></a></sup></p>
<p>Although this disease lacks characterization in the early stages of tumor development, considerations based on diverse clinical manifestations, as well as resistance to <a href="/wiki/Radiation" title="Radiation">radiation</a> and <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> are important. The main diagnostic tools for detecting renal cell carcinoma are <a href="/wiki/Ultrasound" title="Ultrasound">ultrasound</a>, <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> (CT) scanning and <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> (MRI) of the kidneys.<sup id="cite_ref-agabegi2nd_24-0" class="reference"><a href="#cite_note-agabegi2nd-24"><span>[</span>24<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=7" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Renal cell carcinoma (RCC) is not a single entity, but rather a collection of different types of <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumours</a>, each derived from the various parts of the <a href="/wiki/Nephron" title="Nephron">nephron</a> (<a href="/wiki/Epithelium" title="Epithelium">epithelium</a> or <a href="/wiki/Renal_tubules#Renal_tubule" title="Renal tubules" class="mw-redirect">renal tubules</a>) and possessing distinct genetic characteristics, <a href="/wiki/Histology" title="Histology">histological</a> features, and, to some extent, clinical phenotypes.<sup id="cite_ref-rini_21-2" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup></p>
<table class="wikitable collapsible collapsed" style="font-size:88%; width:100%">
<tr>
<th colspan="4">Classification of the Common <a href="/wiki/Histology" title="Histology">Histological</a> Subtypes of Renal Cell Carcinoma<sup id="cite_ref-rini_21-3" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup></th>
</tr>
<tr>
<th>Renal Cell Carcinoma Subtype</th>
<th>Frequency</th>
<th>Genetic Abnormalities</th>
<th>Characteristics</th>
</tr>
<tr>
<td>
<p><b>Clear Cell Renal Cell Carcinoma (CCRCC)</b></p>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Renal_clear_cell_ca_(1)_Nephrectomy.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/Renal_clear_cell_ca_%281%29_Nephrectomy.jpg/220px-Renal_clear_cell_ca_%281%29_Nephrectomy.jpg" width="220" height="166" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6d/Renal_clear_cell_ca_%281%29_Nephrectomy.jpg/330px-Renal_clear_cell_ca_%281%29_Nephrectomy.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6d/Renal_clear_cell_ca_%281%29_Nephrectomy.jpg/440px-Renal_clear_cell_ca_%281%29_Nephrectomy.jpg 2x" data-file-width="2040" data-file-height="1536" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Renal_clear_cell_ca_(1)_Nephrectomy.jpg" class="internal" title="Enlarge"></a></div>
Generally the cells have a clear <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a>, are surrounded by a distinct <a href="/wiki/Cell_membrane" title="Cell membrane">cell membrane</a> and contain round and uniform <a href="/wiki/Cell_nucleus" title="Cell nucleus">nuclei</a>.</div>
</div>
</div>
</div>
</td>
<td>60-70%</td>
<td>
<ul>
<li>Alterations of <a href="/wiki/Chromosome" title="Chromosome">chromosome</a> 3p segments occurs in 70 – 90% of CCRCCs</li>
<li>Inactivation of <a href="/wiki/Von_Hippel%E2%80%93Lindau_tumor_suppressor" title="Von Hippel–Lindau tumor suppressor">von Hippel-Lindau (VHL) gene</a> by <a href="/wiki/Mutation" title="Mutation">mutation</a> and promoter <a href="/wiki/Methylation#Epigenetics" title="Methylation">hypermethylation</a></li>
<li>Gain of chromosome 5q</li>
<li>Loss of chromosomes 8p, 9p, and 14q</li>
<li>In 2009-2010, five new frequently mutated genes were discovered in CCRCC; KDM6A/UTX, SETD2, KDM5C/JARID1C, and MLL2<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></li>
</ul>
</td>
<td>
<ul>
<li>CCRCC is derived from the <a href="/wiki/Proximal_convoluted_tubules" title="Proximal convoluted tubules" class="mw-redirect">proximal convoluted tubule</a></li>
<li>Most commonly affects male patients in their sixties and seventies<sup id="cite_ref-zhou_26-0" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
<li>Majority of CCRCC arise <a href="/wiki/Sporadic_cancer#Heredity" title="Sporadic cancer" class="mw-redirect">sporadically</a><sup id="cite_ref-zhou_26-1" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
<li>Only 2 – 4% of the cases presenting as part of an <a href="/wiki/Heredity" title="Heredity">inherited</a> cancer syndrome<sup id="cite_ref-zhou_26-2" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
</ul>
</td>
</tr>
<tr>
<td><b>Papillary Renal Cell Carcinoma (PRCC)</b>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Papillary_renal_cell_carcinoma_1.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Papillary_renal_cell_carcinoma_1.jpg/220px-Papillary_renal_cell_carcinoma_1.jpg" width="220" height="174" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Papillary_renal_cell_carcinoma_1.jpg/330px-Papillary_renal_cell_carcinoma_1.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0c/Papillary_renal_cell_carcinoma_1.jpg/440px-Papillary_renal_cell_carcinoma_1.jpg 2x" data-file-width="1504" data-file-height="1188" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Papillary_renal_cell_carcinoma_1.jpg" class="internal" title="Enlarge"></a></div>
Type 1 PRCC consist of <a href="/wiki/Renal_papilla" title="Renal papilla">papillae</a> covered with a single or double layer of small <a href="/wiki/Cuboidal_epithelial_cell" title="Cuboidal epithelial cell">cuboid cells</a> with scanty <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a> and Type 2 PRCC consist of papillae covered by large <a href="/wiki/Eosinophilic" title="Eosinophilic">eosinophilic</a> cells arranged in an irregular or <a href="/wiki/Epithelium" title="Epithelium">pseudostratified</a> manner.</div>
</div>
</div>
</div>
</td>
<td>10–15%</td>
<td>
<ul>
<li><a href="/wiki/Trisomy" title="Trisomy">Trisomy</a> or <a href="/wiki/Tetrasomy" title="Tetrasomy">tetrasomy</a> of chromosomes 7 and 17</li>
<li>Loss of chromosome Y in men</li>
<li>Gain of chromosomes 12, 16, and 20</li>
<li>Rare mutations of <a href="/wiki/Met_proto-oncogene#proto-oncogene" title="Met proto-oncogene" class="mw-redirect">Met</a><a href="/wiki/Proto-oncogene#Proto-oncogene" title="Proto-oncogene" class="mw-redirect">proto-oncogene</a></li>
</ul>
</td>
<td>
<ul>
<li>PRCC is derived from the <a href="/wiki/Proximal_convoluted_tubule" title="Proximal convoluted tubule">proximal convoluted tubule</a></li>
<li>PRCCs most commonly affect males in their sixties and seventies<sup id="cite_ref-zhou_26-3" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
<li>Less aggressive tumour than clear cell RCC, with 5-year survival rates of 80% to 85%.</li>
<li>Majority of tumours occur <a href="/wiki/Sporadic_cancer" title="Sporadic cancer" class="mw-redirect">sporadically</a>, but some may develop in members of families with <a href="/wiki/Hereditary" title="Hereditary" class="mw-redirect">hereditary</a> PRCC<sup id="cite_ref-zhou_26-4" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
</ul>
</td>
</tr>
<tr>
<td><b><a href="/wiki/Chromophobe" title="Chromophobe" class="mw-redirect">Chromophobe</a> Renal Cell Carcinoma (ChRCC)</b>
<div class="center">
<div class="thumb tnone">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Oncocytic_chromophobe_rcc_high_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Oncocytic_chromophobe_rcc_high_mag.jpg/220px-Oncocytic_chromophobe_rcc_high_mag.jpg" width="220" height="300" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Oncocytic_chromophobe_rcc_high_mag.jpg/330px-Oncocytic_chromophobe_rcc_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Oncocytic_chromophobe_rcc_high_mag.jpg/440px-Oncocytic_chromophobe_rcc_high_mag.jpg 2x" data-file-width="1920" data-file-height="2616" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Oncocytic_chromophobe_rcc_high_mag.jpg" class="internal" title="Enlarge"></a></div>
ChRCC consists of tumor cells with abundant <a href="/wiki/Eosinophilic" title="Eosinophilic">eosinophilic</a> cytoplasm (pale cells and eosinophilic cells with a perinuclear halo) and show mainly a solid structure.</div>
</div>
</div>
</div>
</td>
<td>3–5%</td>
<td>
<ul>
<li>Loss of chromosomes Y, 1, 2, 6, 10, 13, 17, and 21</li>
</ul>
</td>
<td>
<ul>
<li>ChRCC is derived from the <a href="/wiki/Cortical_collecting_duct" title="Cortical collecting duct" class="mw-redirect">cortical collecting duct</a></li>
<li>ChRCC has a much better <a href="/wiki/Prognosis" title="Prognosis">prognosis</a> than clear cell and papillary RCC, with 5-year survival rate of greater than 90%.</li>
<li>Most cases arise <a href="/wiki/Sporadic_cancer" title="Sporadic cancer" class="mw-redirect">sporadically</a>, while some familial cases are associated with <a href="/wiki/Birt%E2%80%93Hogg%E2%80%93Dub%C3%A9_syndrome" title="Birt–Hogg–Dubé syndrome">Birt-Hogg-Dube (BHD) syndrome</a><sup id="cite_ref-zhou_26-5" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup></li>
</ul>
</td>
</tr>
</table>
<table class="wikitable collapsible collapsed" style="font-size:88%; width:100%">
<tr>
<th colspan="5">Clinical, Pathological and Genetic Features of Uncommon RCC Subtypes Included in the 2004 WHO Classification of RCC Pathology<sup id="cite_ref-zhou_26-6" class="reference"><a href="#cite_note-zhou-26"><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></th>
</tr>
<tr>
<th>RCC subtype</th>
<th>Clinical features</th>
<th>Cell/Tissue Characteristics</th>
<th>Genetics</th>
<th>Prognosis</th>
</tr>
<tr>
<td><b>Multilocular Cystic RCC</b></td>
<td>
<ul>
<li>Variant of CCRCC (5% of CCRCC)</li>
<li>Mean age 51 years (range 20–76)</li>
<li>Male:female = 2–3:1</li>
</ul>
</td>
<td>Clear <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a>, small dark <a href="/wiki/Cell_nucleus" title="Cell nucleus">nuclei</a></td>
<td>3p deletion as observed in CCRCC</td>
<td>
<ul>
<li>Favorable</li>
<li>No local or distant <a href="/wiki/Metastasis" title="Metastasis">metastasis</a> after complete surgical removal</li>
</ul>
</td>
</tr>
<tr>
<td><b>Carcinoma of the <a href="/wiki/Duct_of_Bellini" title="Duct of Bellini" class="mw-redirect">Collecting Ducts of Bellini</a></b></td>
<td>
<ul>
<li>Less than 1% of all renal tumors; arising in the <a href="/wiki/Duct_of_Bellini" title="Duct of Bellini" class="mw-redirect">collecting ducts of Bellini</a></li>
<li>Mean age 55 years (range 40-70)</li>
<li>Male:female = 2:1</li>
</ul>
</td>
<td>High-grade tumor cells with <a href="/wiki/Eosinophilic" title="Eosinophilic">eosinophilic</a> <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a></td>
<td>Variable results: LOH on chromosomes 1q, 6p, 8p,9p, 13q, 19q32 and 21q; c-erB2 amplification associated with unfavorable outcome</td>
<td>
<ul>
<li>Poor prognosis</li>
<li>1/3 presenting with <a href="/wiki/Metastasis" title="Metastasis">metastasis</a></li>
<li>2/3 patients succumb to the disease within 2 years of diagnosis</li>
</ul>
</td>
</tr>
<tr>
<td><b>Medullary Carcinoma</b></td>
<td>
<ul>
<li>Exceedingly rare; almost exclusively in patients with <a href="/wiki/Sickle-cell_disease" title="Sickle-cell disease">sickle cell hemoglobinopathies or traits</a></li>
<li>Majority are African-Americans</li>
<li>Mean age 19 years (5–69)</li>
<li>Male:female = 2:1</li>
</ul>
</td>
<td><a href="/wiki/Haemorrhage" title="Haemorrhage" class="mw-redirect">Haemorrhage</a> and <a href="/wiki/Necrosis" title="Necrosis">necrosis</a>, high-grade tumour cells with eosinophilic cytoplasm</td>
<td>Not well defined</td>
<td>
<ul>
<li>Highly aggressive</li>
<li>95% presenting with <a href="/wiki/Metastasis" title="Metastasis">metastasis</a></li>
<li>Often succumb to the disease within 6 months of diagnosis</li>
</ul>
</td>
</tr>
<tr>
<td><b>Xp11.2 Translocation Carcinoma</b></td>
<td>
<ul>
<li>Predominantly affecting children and young adults</li>
<li>Accounts for 40% of RCCs in this age group</li>
<li>Affects adult patients with a striking female predominance</li>
</ul>
</td>
<td>
<ul>
<li>May resemble PRCC</li>
<li>Clear and <a href="/wiki/Eosinophilic" title="Eosinophilic">eosinophilic</a> cells</li>
</ul>
</td>
<td><a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">Chromosomal translocation</a> involving <a href="/wiki/TFE3" title="TFE3">TFE3</a> gene on Xp11.2 resulting in <a href="/wiki/Overexpression" title="Overexpression" class="mw-redirect">overexpression</a> of the TFE3 protein</td>
<td>
<ul>
<li>Present at advanced stage, but with indolent clinical course in children</li>
<li>Adult patients may pursue more aggressive course</li>
</ul>
</td>
</tr>
<tr>
<td><b>Mucinous Tubular Spindle Cell Carcinoma</b></td>
<td>
<ul>
<li>Mean age 53 years (range 13–82)</li>
<li>Affects predominantly female patients (male:female = 1:4) incidental finding in most cases</li>
</ul>
</td>
<td>Tubules, extracellular <a href="/wiki/Mucin" title="Mucin">mucin</a> and <a href="/wiki/Spindle_cells" title="Spindle cells" class="mw-redirect">spindle cells</a></td>
<td>Not well defined; Losses involving chromosomes 1, 4, 6, 8, 9, 11, 13, 14, 15, 18, 22 reported; 3p alterations and gain of chromosome 7, and 17 not present</td>
<td>
<ul>
<li>Favourable</li>
<li>Majority of patients remain disease free after surgical resection</li>
</ul>
</td>
</tr>
<tr>
<td><b>Post-Neuroblastoma Renal Cell Carcinoma</b></td>
<td>
<ul>
<li>Mean age of RCC diagnosis is 13.5 years (range 2–35)</li>
</ul>
</td>
<td>Eosinophilic cells with <a href="/wiki/Oncocytoma" title="Oncocytoma">oncocytoid</a> features (same as CCRCC)</td>
<td>Not well defined; Loss of multiple chromosomal <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">loci</a> observed</td>
<td>Similar to other common RCC subtypes</td>
</tr>
</table>
<p>Array-based karyotyping can be used to identify characteristic chromosomal aberrations in renal tumors with challenging morphology.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup> Array-based karyotyping performs well on paraffin embedded tumours<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> and is amenable to routine clinical use. See also <a href="/wiki/Virtual_Karyotype" title="Virtual Karyotype" class="mw-redirect">Virtual Karyotype</a> for CLIA certified laboratories offering array-based karyotyping of solid tumours.</p>
<p>The 2004 <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) classification of genitourinary tumours recognizes over 40 subtypes of <a href="/w/index.php?title=Renal_neoplasm&amp;action=edit&amp;redlink=1" class="new" title="Renal neoplasm (page does not exist)">renal neoplasms</a>. Since the publication of the latest iteration of the WHO classification in 2004, several novel renal tumour subtypes have been described:<sup id="cite_ref-pmid24364021_31-0" class="reference"><a href="#cite_note-pmid24364021-31"><span>[</span>31<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Clear_cell_papillary_renal_cell_carcinoma" title="Clear cell papillary renal cell carcinoma">Clear cell papillary renal cell carcinoma</a> and <a href="/wiki/Clear_cell_renal_cell_carcinoma_with_smooth_muscle_stroma" title="Clear cell renal cell carcinoma with smooth muscle stroma" class="mw-redirect">Clear cell renal cell carcinoma with smooth muscle stroma</a><sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup></li>
<li><a href="/wiki/Mucinous_tubular_and_spindle_cell_carcinoma" title="Mucinous tubular and spindle cell carcinoma">Mucinous tubular and spindle cell carcinoma</a> (MTSCC) <sup id="cite_ref-pmid24364021_31-1" class="reference"><a href="#cite_note-pmid24364021-31"><span>[</span>31<span>]</span></a></sup></li>
<li><a href="/wiki/Multilocular_cystic_clear_cell_renal_cell_carcinoma" title="Multilocular cystic clear cell renal cell carcinoma">Multilocular cystic clear cell renal cell carcinoma</a> <sup id="cite_ref-pmid24364021_31-2" class="reference"><a href="#cite_note-pmid24364021-31"><span>[</span>31<span>]</span></a></sup></li>
<li><a href="/wiki/Tubulocystic_renal_cell_carcinoma" title="Tubulocystic renal cell carcinoma">Tubulocystic renal cell carcinoma</a></li>
<li><a href="/wiki/Thyroid-like_follicular_renal_cell_carcinoma" title="Thyroid-like follicular renal cell carcinoma">Thyroid-like follicular renal cell carcinoma</a></li>
<li><a href="/wiki/Acquired_cystic_kidney_disease-associated_renal_cell_carcinoma" title="Acquired cystic kidney disease-associated renal cell carcinoma">Acquired cystic kidney disease-associated renal cell carcinoma</a></li>
<li><a href="/wiki/Renal_cell_carcinoma_with_t(6;11)_translocation" title="Renal cell carcinoma with t(6;11) translocation">Renal cell carcinoma with t(6;11) translocation</a> (TFEB)</li>
<li><a href="/wiki/Hybrid_oncocytoma/chromophobe_renal_cell_carcinoma" title="Hybrid oncocytoma/chromophobe renal cell carcinoma">Hybrid oncocytoma/chromophobe renal cell carcinoma</a></li>
<li><a href="/wiki/Hereditary_leiomyomatosis_and_renal_cell_carcinoma" title="Hereditary leiomyomatosis and renal cell carcinoma">Hereditary leiomyomatosis and renal cell carcinoma</a>(HLRCC)</li>
</ul>
<h3><span class="mw-headline" id="Laboratory_tests">Laboratory tests</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=8" title="Edit section: Laboratory tests">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Laboratory tests are generally conducted when the patient presents signs and symptoms that may be characteristic of kidney impairment. They are not primarily used to diagnose kidney cancer, due to its <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a> nature and are generally found incidentally during tests for other illnesses such as <a href="/wiki/Gallbladder" title="Gallbladder">gallbladder</a> disease.<sup id="cite_ref-Wood_33-0" class="reference"><a href="#cite_note-Wood-33"><span>[</span>33<span>]</span></a></sup> In other words, these cancers are not detected usually because they do not cause pain or discomfort when they are discovered. Laboratory analysis can provide an assessment on the overall health of the patient and can provide information in determining the staging and degree of <a href="/wiki/Metastasis" title="Metastasis">metastasis</a> to other parts of the body (if a renal <a href="/wiki/Lesion" title="Lesion">lesion</a> has been identified) before treatment is given.</p>
<h4><span class="mw-headline" id="Urine_analysis">Urine analysis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=9" title="Edit section: Urine analysis">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The presence of blood in urine is a common presumptive sign of renal cell carcinoma. The <a href="/wiki/Haemoglobin" title="Haemoglobin" class="mw-redirect">haemoglobin</a> of the blood causes the urine to be rusty, brown or red in colour. Alternatively, <a href="/wiki/Urinalysis" title="Urinalysis">urinalysis</a> can test for <a href="/wiki/Sugar" title="Sugar">sugar</a>, <a href="/wiki/Protein" title="Protein">protein</a> and <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> which can also serve as indicators for <a href="/wiki/Cancer" title="Cancer">cancer</a>. A complete blood cell count can also provide additional information regarding the severity and spreading of the <a href="/wiki/Cancer" title="Cancer">cancer</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Complete_blood_cell_count">Complete blood cell count</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=10" title="Edit section: Complete blood cell count">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The CBC provides a quantified measure of the different cells in the whole blood sample from the patient. Such cells examined for in this test include red blood cells (<a href="/wiki/Erythrocytes" title="Erythrocytes" class="mw-redirect">erythrocytes</a>), white blood cells (<a href="/wiki/Leukocytes" title="Leukocytes" class="mw-redirect">leukocytes</a>) and <a href="/wiki/Platelets" title="Platelets" class="mw-redirect">platelets</a> (<a href="/wiki/Thrombocytes" title="Thrombocytes" class="mw-redirect">thrombocytes</a>). A common sign of renal cell carcinoma is <a href="/wiki/Anaemia" title="Anaemia" class="mw-redirect">anaemia</a> whereby the patient exhibits deficiency in red blood cells.<sup id="cite_ref-Johann_35-0" class="reference"><a href="#cite_note-Johann-35"><span>[</span>35<span>]</span></a></sup> CBC tests are vital as a screening tool for examination the health of patient prior to surgery. Inconsistencies with platelet counts are also common amongst these cancer patients and further coagulation tests, including <a href="/wiki/Erythrocyte_Sedimentation_Rate" title="Erythrocyte Sedimentation Rate" class="mw-redirect">Erythrocyte Sedimentation Rate</a> (ESR), Prothrombin Time (PT), <a href="/wiki/Activated_Partial_Thromboplastin_Time" title="Activated Partial Thromboplastin Time" class="mw-redirect">Activated Partial Thromboplastin Time</a> (APTT) should be considered.</p>
<h4><span class="mw-headline" id="Blood_chemistry">Blood chemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=11" title="Edit section: Blood chemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Blood chemistry tests are conducted if renal cell carcinoma is suspected as <a href="/wiki/Cancer" title="Cancer">cancer</a> has the potential to elevate levels of particular chemicals in blood. For example, liver <a href="/wiki/Enzymes" title="Enzymes" class="mw-redirect">enzymes</a> such as <a href="/wiki/Aspartate_aminotransferase" title="Aspartate aminotransferase" class="mw-redirect">aspartate aminotransferase</a> [AST] and <a href="/wiki/Alanine_aminotransferase" title="Alanine aminotransferase" class="mw-redirect">alanine aminotransferase</a> [ALT] are found to be at abnormally high levels.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> The staging of the cancer can also be determined by abnormal elevated levels of calcium, which suggests that the cancer may have metastasised to the bones.<sup id="cite_ref-Motzer_37-0" class="reference"><a href="#cite_note-Motzer-37"><span>[</span>37<span>]</span></a></sup> In this case, a doctor should be prompted for a CT scan. Blood chemistry tests also assess the overall function of the kidneys and can allow the doctor to decide upon further radiological tests.</p>
<h3><span class="mw-headline" id="Radiology">Radiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=12" title="Edit section: Radiology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The characteristic appearance of renal cell carcinoma (RCC) is a solid renal lesion which disturbs the renal contour. It will frequently have an irregular or lobulated margin and may be seen as a lump on the lower pelvic or abdomen region. Traditionally, 85 to 90% of solid renal masses will turn out to be RCC but cystic renal masses may also be due to RCC.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup> However, the advances of diagnostic modalities are able to incidentally diagnose a great proportion of patients with renal lesions that may appear to be small in size and of benign state. Ten percent of RCC will contain <a href="/wiki/Calcification" title="Calcification">calcifications</a>, and some contain <a href="/wiki/Macroscopic" title="Macroscopic" class="mw-redirect">macroscopic</a> fat (likely due to invasion and encasement of the perirenal fat.<sup id="cite_ref-Nakada_39-0" class="reference"><a href="#cite_note-Nakada-39"><span>[</span>39<span>]</span></a></sup> Deciding on the <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> or <a href="/wiki/Malignant" title="Malignant" class="mw-redirect">malignant</a> nature of the renal mass on the basis of its localized size is an issue as renal cell carcinoma may also be cystic. As there are several benign cystic renal lesions (simple renal cyst, <a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">haemorrhagic</a> renal cyst, <a href="/wiki/Multilocular_cystic_nephroma" title="Multilocular cystic nephroma" class="mw-redirect">multilocular cystic nephroma</a>, <a href="/wiki/Polycystic_kidney_disease" title="Polycystic kidney disease">polycystic kidney disease</a>), it may occasionally be difficult for the radiologist to differentiate a <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> cystic lesion from a malignant one.<sup id="cite_ref-Pattamapaspong_40-0" class="reference"><a href="#cite_note-Pattamapaspong-40"><span>[</span>40<span>]</span></a></sup> The Bosniak classification system for cystic renal <a href="/wiki/Lesions" title="Lesions" class="mw-redirect">lesions</a> classifies them into groups that are <a href="/wiki/Benign" title="Benign" class="mw-redirect">benign</a> and those that need <a href="/wiki/Surgical_resection" title="Surgical resection" class="mw-redirect">surgical resection</a>, based on specific imaging features.<sup id="cite_ref-Israel_41-0" class="reference"><a href="#cite_note-Israel-41"><span>[</span>41<span>]</span></a></sup></p>
<p>The main imaging tests performed in order to identify renal cell carcinoma are pelvic and abdominal CT scans, ultrasound tests of the kidneys (ultrasonography), MRI scans, intravenous pyelogram (IVP) or renal angiography.<sup id="cite_ref-Jubelirer_42-0" class="reference"><a href="#cite_note-Jubelirer-42"><span>[</span>42<span>]</span></a></sup> Among these main diagnostic tests, other radiologic tests such as excretory <a href="/wiki/Urography" title="Urography" class="mw-redirect">urography</a>, <a href="/wiki/Positron-emission_tomography" title="Positron-emission tomography" class="mw-redirect">positron-emission tomography</a> (PET) scanning, <a href="/wiki/Ultrasonography" title="Ultrasonography" class="mw-redirect">ultrasonography</a>, <a href="/wiki/Arteriography" title="Arteriography" class="mw-redirect">arteriography</a>, <a href="/wiki/Venography" title="Venography">venography</a>, and bone scanning can also used to aid in the evaluation of staging renal masses and to differentiate non-malignant tumours from malignant tumours.</p>
<h4><span class="mw-headline" id="Computed_tomography">Computed tomography</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=13" title="Edit section: Computed tomography">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Contrast-enhanced <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">Computed tomography</a> (CT) scanning is a routinely used imaging procedure in determining the stage of the renal cell carcinoma in the <a href="/wiki/Abdominal" title="Abdominal" class="mw-redirect">abdominal</a> and <a href="/wiki/Pelvic" title="Pelvic" class="mw-redirect">pelvic</a> regions of the patient. CT scans have the potential to distinguish solid masses from cystic masses and may provide information on the localization, stage or spread of the cancer to other organs of the patient. Key parts of the human body which are examined for <a href="/wiki/Metastatic" title="Metastatic" class="mw-redirect">metastatic</a> involvement of renal cell carcinoma may include the <a href="/wiki/Renal_vein" title="Renal vein">renal vein</a>, <a href="/wiki/Lymph_node" title="Lymph node">lymph node</a> and the involvement of the <a href="/wiki/Inferior_vena_cava" title="Inferior vena cava">inferior vena cava</a>.<sup id="cite_ref-Beck_43-0" class="reference"><a href="#cite_note-Beck-43"><span>[</span>43<span>]</span></a></sup> According to a study conducted by Sauk et al., multidetector CT imaging characteristics have applications in diagnosing patients with clear renal cell carcinoma by depicting the differences of these cells at the cytogenic level.<sup id="cite_ref-Sauk_44-0" class="reference"><a href="#cite_note-Sauk-44"><span>[</span>44<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Ultrasound">Ultrasound</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=14" title="Edit section: Ultrasound">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Ultrasonographic examination can be useful in evaluating questionable <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a> kidney <a href="/wiki/Tumours" title="Tumours" class="mw-redirect">tumours</a> and cystic renal <a href="/wiki/Lesions" title="Lesions" class="mw-redirect">lesions</a> if <a href="/wiki/Computed_Tomography" title="Computed Tomography" class="mw-redirect">Computed Tomography</a> imaging is inconclusive. This safe and non-invasive radiologic procedure uses high frequency sound waves to generate an interior image of the body on a computer monitor. The image generated by the <a href="/wiki/Ultrasound" title="Ultrasound">ultrasound</a> can help diagnose renal cell carcinoma based on the differences of sound reflections on the surface of organs and the abnormal tissue masses. Essentially, ultrasound tests can determine whether the composition of the kidney mass is mainly solid or filled with fluid.<sup id="cite_ref-Jubelirer_42-1" class="reference"><a href="#cite_note-Jubelirer-42"><span>[</span>42<span>]</span></a></sup></p>
<p>A <a href="/wiki/Percutaneous_biopsy" title="Percutaneous biopsy" class="mw-redirect">Percutaneous biopsy</a> can be performed by a radiologist using ultrasound or computed tomography to guide sampling of the tumour for the purpose of diagnosis by <a href="/wiki/Pathology" title="Pathology">pathology</a>. However this is not routinely performed because when the typical imaging features of renal cell carcinoma are present, the possibility of an incorrectly negative result together with the risk of a medical complication to the patient may make it unfavourable from a risk-benefit perspective.<sup id="cite_ref-Lane_11-1" class="reference"><a href="#cite_note-Lane-11"><span>[</span>11<span>]</span></a></sup> However, biopsy tests for molecular analysis to distinguish benign from malignant renal tumours is of investigative interest.<sup id="cite_ref-Lane_11-2" class="reference"><a href="#cite_note-Lane-11"><span>[</span>11<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Magnetic_resonance_imaging">Magnetic resonance imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=15" title="Edit section: Magnetic resonance imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Magnetic_Resonance_Imaging" title="Magnetic Resonance Imaging" class="mw-redirect">Magnetic Resonance Imaging</a> (MRI) scans provide an image of the soft tissues in the body using radio waves and strong magnets. MRI can be used instead of CT if the patient exhibits an allergy to the contrast media administered for the test.<sup id="cite_ref-Hricak_45-0" class="reference"><a href="#cite_note-Hricak-45"><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-Janus_46-0" class="reference"><a href="#cite_note-Janus-46"><span>[</span>46<span>]</span></a></sup> Sometimes prior to the MRI scan, an <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> injection of a contrasting material called <a href="/wiki/Gadolinium" title="Gadolinium">gadolinium</a> is given to allow for a more detailed image. Patients on dialysis or those who have renal insufficiency should avoid this contrasting material as it may induce a rare, yet severe, side effect known as nephrogenic systemic fibrosis.<sup id="cite_ref-Nishimura_47-0" class="reference"><a href="#cite_note-Nishimura-47"><span>[</span>47<span>]</span></a></sup> A bone scan or brain imaging is not routinely performed unless signs or symptoms suggest potential metastatic involvement of these areas. MRI scans should also be considered to evaluate <a href="/wiki/Tumor" title="Tumor" class="mw-redirect">tumour</a> extension which has grown in major blood vessels, including the <a href="/wiki/Vena_cava" title="Vena cava" class="mw-redirect">vena cava</a>, in the abdomen. MRI can be used to observe the possible spread of cancer to the <a href="/wiki/Brain" title="Brain">brain</a> or <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> should the patient present symptoms that suggest this might be the case.</p>
<h4><span class="mw-headline" id="Intravenous_pyelogram">Intravenous pyelogram</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=16" title="Edit section: Intravenous pyelogram">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Intravenous_pyelogram" title="Intravenous pyelogram">Intravenous pyelogram</a> (IVP) is a useful procedure in detecting the presence of abnormal renal mass in the <a href="/wiki/Urinary_tract" title="Urinary tract" class="mw-redirect">urinary tract</a>. This procedure involves the injection of a contrasting dye into the arm of the patient. The dye travels from the blood stream and into the kidneys which in time, passes into the kidneys and bladder. This test is not necessary if a CT or MRI scan has been conducted.<sup id="cite_ref-Reznek_48-0" class="reference"><a href="#cite_note-Reznek-48"><span>[</span>48<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Renal_angiography">Renal angiography</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=17" title="Edit section: Renal angiography">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Renal <a href="/wiki/Angiography" title="Angiography">angiography</a> uses the same principle as IVP, as this type of <a href="/wiki/X-ray" title="X-ray">X-ray</a> also uses a contrasting dye. This radiologic test is important in diagnosing renal cell carcinoma as an aid for examining <a href="/wiki/Blood_vessels" title="Blood vessels" class="mw-redirect">blood vessels</a> in the kidneys. This diagnostic test relies on the contrasting agent which is injected in the renal artery to be absorbed by the cancerous cells.<sup id="cite_ref-Kocak_49-0" class="reference"><a href="#cite_note-Kocak-49"><span>[</span>49<span>]</span></a></sup> The contrasting dye provides a clearer outline of abnormally-oriented blood vessels believed to be involved with the tumour. This is imperative for surgeons as it allows the patient’s blood vessels to be mapped prior to operation.<sup id="cite_ref-Beck_43-1" class="reference"><a href="#cite_note-Beck-43"><span>[</span>43<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=18" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/Cancer_staging" title="Cancer staging">staging</a> of renal cell carcinoma is the most important factor in predicting its prognosis.<sup id="cite_ref-cornellurology_50-0" class="reference"><a href="#cite_note-cornellurology-50"><span>[</span>50<span>]</span></a></sup> Staging can follow the <a href="/wiki/TNM_staging_system" title="TNM staging system">TNM staging system</a>, where the size and extent of the tumour (T), involvement of lymph nodes (N) and metastases (M) are classified separately. Also, it can use overall stage grouping into stage I-IV, with the 1997 revision of AJCC described below:<sup id="cite_ref-cornellurology_50-1" class="reference"><a href="#cite_note-cornellurology-50"><span>[</span>50<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<td><b>Stage I</b></td>
<td>Tumour of a diameter of 7&#160;cm (approx. 23⁄4 inches) or smaller, and limited to the kidney. No lymph node involvement or metastases to distant organs.</td>
</tr>
<tr>
<td><b>Stage II</b></td>
<td>Tumour larger than 7.0&#160;cm but still limited to the kidney. No lymph node involvement or metastases to distant organs.</td>
</tr>
<tr>
<td rowspan="2"><b>Stage III</b><br />
any of the following</td>
<td>Tumor of any size with involvement of a nearby lymph node but no metastases to distant organs. Tumour of this stage may be with or without spread to fatty tissue around the kidney, with or without spread into the large veins leading from the kidney to the heart.</td>
</tr>
<tr>
<td>Tumour with spread to fatty tissue around the kidney and/or spread into the large veins leading from the kidney to the heart, but without spread to any lymph nodes or other organs.</td>
</tr>
<tr>
<td rowspan="4"><b>Stage IV</b><br />
any of the following</td>
<td>Tumour that has spread directly through the fatty tissue and the fascia ligament-like tissue that surrounds the kidney.</td>
</tr>
<tr>
<td>Involvement of more than one lymph node near the kidney</td>
</tr>
<tr>
<td>Involvement of any lymph node not near the kidney</td>
</tr>
<tr>
<td>Distant metastases, such as in the lungs, bone, or brain.</td>
</tr>
</table>
<p>At diagnosis, 30% of renal cell carcinomas have spread to the ipsilateral renal vein, and 5-10% have continued into the inferior vena cava.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Histopathology">Histopathology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=19" title="Edit section: Histopathology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Renal_cell_carcinoma.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Renal_cell_carcinoma.jpg/220px-Renal_cell_carcinoma.jpg" width="220" height="306" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Renal_cell_carcinoma.jpg/330px-Renal_cell_carcinoma.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Renal_cell_carcinoma.jpg/440px-Renal_cell_carcinoma.jpg 2x" data-file-width="467" data-file-height="650" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Renal_cell_carcinoma.jpg" class="internal" title="Enlarge"></a></div>
Renal cell carcinoma</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Kidney_cancer.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/8/88/Kidney_cancer.jpg/220px-Kidney_cancer.jpg" width="220" height="277" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/88/Kidney_cancer.jpg/330px-Kidney_cancer.jpg 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/88/Kidney_cancer.jpg/440px-Kidney_cancer.jpg 2x" data-file-width="526" data-file-height="663" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Kidney_cancer.jpg" class="internal" title="Enlarge"></a></div>
Renal cell carcinoma</div>
</div>
</div>
<p>The gross and microscopic appearance of renal cell carcinomas is highly variable. The renal cell carcinoma may present reddened areas where <a href="/wiki/Blood_vessels" title="Blood vessels" class="mw-redirect">blood vessels</a> have bled, and cysts containing watery fluids.<sup id="cite_ref-Brit_52-0" class="reference"><a href="#cite_note-Brit-52"><span>[</span>52<span>]</span></a></sup> The body of the tumour shows large blood vessels that have walls composed of cancerous cells. <a href="/wiki/Gross_examination" title="Gross examination">Gross examination</a> often shows a yellowish, multilobulated tumor in the <a href="/wiki/Renal_cortex" title="Renal cortex">renal cortex</a>, which frequently contains zones of <a href="/wiki/Necrosis" title="Necrosis">necrosis</a>, <a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">haemorrhage</a> and <a href="/wiki/Scarring" title="Scarring" class="mw-redirect">scarring</a>. In a microscopic context, there are four major histologic subtypes of renal cell cancer: clear cell (conventional RCC, 75%), papillary (15%), chromophobic (5%), and collecting duct (2%). Sarcomatoid changes (morphology and patterns of IHC that mimic sarcoma, spindle cells) can be observed within any RCC subtype and are associated with more aggressive clinical course and worse prognosis. Under light microscopy, these <a href="/wiki/Tumour" title="Tumour" class="mw-redirect">tumour</a> cells can exhibit <a href="/wiki/Papilla_(disambiguation)" title="Papilla (disambiguation)" class="mw-redirect">papillae</a>, tubules or nests, and are quite large, atypical, and polygonal.</p>
<p>Recent studies have brought attention to the close association of the type of cancerous cells to the aggressiveness of the condition. Some studies suggest that these cancerous cells accumulate glycogen and lipids, their cytoplasm appear "clear", the nuclei remain in the middle of the cells, and the cellular membrane is evident.<sup id="cite_ref-Vasileva_53-0" class="reference"><a href="#cite_note-Vasileva-53"><span>[</span>53<span>]</span></a></sup> Some cells may be smaller, with eosinophilic cytoplasm, resembling normal tubular cells. The stroma is reduced, but well vascularised. The tumour compresses the surrounding parenchyma, producing a pseudocapsule.<sup id="cite_ref-title_54-0" class="reference"><a href="#cite_note-title-54"><span>[</span>54<span>]</span></a></sup></p>
<p>The most common cell type exhibited by renal cell carcinoma is the <a href="/wiki/Clear-cell_sarcoma_of_the_kidney" title="Clear-cell sarcoma of the kidney">clear cell</a>, which is named by the dissolving of the cells' high lipid content in the cytoplasm. The clear cells are thought to be the least likely to spread and usually respond more favourably to treatment. However, most of the tumours contain a mixture of cells. The most aggressive stage of renal cancer is believed to be the one in which the tumour is mixed, containing both clear and granular cells.<sup id="cite_ref-Lopez_55-0" class="reference"><a href="#cite_note-Lopez-55"><span>[</span>55<span>]</span></a></sup></p>
<p>The recommended histologic grading schema for RCC is the Fuhrman system (1982), which is an assessment based on the microscopic morphology of a <a href="/wiki/Neoplasm" title="Neoplasm">neoplasm</a> with <a href="/wiki/Haematoxylin" title="Haematoxylin">haematoxylin</a> and <a href="/wiki/Eosin" title="Eosin">eosin</a> (H&amp;E staining). This system categorises renal cell carcinoma with grades 1, 2, 3, 4 based on nuclear characteristics. The details of the Fuhrman grading system for RCC are shown below:<sup id="cite_ref-Rioux_56-0" class="reference"><a href="#cite_note-Rioux-56"><span>[</span>56<span>]</span></a></sup></p>
<table class="wikitable">
<tr>
<th>Grade Level</th>
<th>Nuclear Characteristics</th>
</tr>
<tr>
<td><b>Grade I</b></td>
<td>Nuclei appear round and uniform, 10 μm; nucleoli are inconspicuous or absent.</td>
</tr>
<tr>
<td><b>Grade II</b></td>
<td>Nuclei have an irregular appearance with signs of lobe formation, 15 μm; nucleoli are evident.</td>
</tr>
<tr>
<td><b>Grade III</b></td>
<td>Nuclei appear very irregular, 20 μm; nucleoli are large and prominent.</td>
</tr>
<tr>
<td><b>Grade IV</b></td>
<td>Nuclei appear bizarre and multilobated, 20 μm or more; nucleoli are prominent.</td>
</tr>
</table>
<p>Nuclear grade is believed to be one of the most imperative prognostic factors in patients with renal cell carcinoma.<sup id="cite_ref-rini_21-4" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup> However, a study by Delahunt et al. (2007) has shown that the Fuhrman grading is ideal for clear cell carcinoma but may not be appropriate for chromophobe renal cell carcinomas and that the staging of cancer (accomplished by CT scan) is a more favourable predictor of the prognosis of this disease.<sup id="cite_ref-Delahunt_57-0" class="reference"><a href="#cite_note-Delahunt-57"><span>[</span>57<span>]</span></a></sup> In relation to renal cancer staging, the Heidelberg classification system of renal tumours was introduced in 1976 as a means of more completely correlating the histopathological features with the identified genetic defects.<sup id="cite_ref-Kovacs_58-0" class="reference"><a href="#cite_note-Kovacs-58"><span>[</span>58<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=20" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">For more details on this topic, see <a href="/wiki/Treatment_and_prognosis_of_renal_cell_carcinoma" title="Treatment and prognosis of renal cell carcinoma">Treatment and prognosis of renal cell carcinoma</a>.</div>
<p>The type of treatment depends on multiple factors and the individual, some of which include:<sup id="cite_ref-cohen_7-6" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-simmons_59-0" class="reference"><a href="#cite_note-simmons-59"><span>[</span>59<span>]</span></a></sup></p>
<ul>
<li>Stage of renal cell carcinoma</li>
<li>Organs and parts of the body affected/unaffected</li>
<li>Type of renal cell carcinoma</li>
<li>Pre-existing or comorbid conditions</li>
<li>Overall health and age of the person</li>
</ul>
<p>Every form of treatment has both risks and benefits; a health care professional will provide the best options that suit the individual circumstances.</p>
<h3><span class="mw-headline" id="Active_surveillance">Active surveillance</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=21" title="Edit section: Active surveillance">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Active surveillance or "watchful waiting" is becoming more common as small renal masses or tumours are being detected and also within the older generation when surgery is not always suitable.<sup id="cite_ref-smaldone_60-0" class="reference"><a href="#cite_note-smaldone-60"><span>[</span>60<span>]</span></a></sup> Active surveillance involves completing various diagnostic procedures, tests and imaging to monitor the progression of the RCC before embarking on a more high risk treatment option like surgery.<sup id="cite_ref-smaldone_60-1" class="reference"><a href="#cite_note-smaldone-60"><span>[</span>60<span>]</span></a></sup> In the elderly, patients with co-morbidities, and in poor surgical candidates, this is especially useful.</p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=22" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Different procedures may be most appropriate, depending on circumstances.</p>
<p><b>Radical nephrectomy</b> is the removal of the entire affected kidney including <a href="/wiki/Renal_fascia" title="Renal fascia">Gerota's fascia</a>, the <a href="/wiki/Adrenal_gland" title="Adrenal gland">adrenal gland</a> which is on the same side as the affected kidney, and the regional lymph nodes, all at the same time.<sup id="cite_ref-cohen_7-7" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> This method, although severe, is effective. But it is not always appropriate, as it is a major surgery that contains the risk of complication both during and after the surgery and can have a longer recovery time.<sup id="cite_ref-casey_61-0" class="reference"><a href="#cite_note-casey-61"><span>[</span>61<span>]</span></a></sup> It is important to note that the other kidney must be fully functional, and this technique is most often used when there is a large tumour present in only one kidney.</p>
<p><a href="/wiki/Nephrectomy#Partial_Nephrectomy" title="Nephrectomy"><b>Nephron-sparing partial nephrectomy</b></a> is used when the tumor is small (less than 4&#160;cm in diameter) or when the patient has other medical concerns such as <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a> or <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>.<sup id="cite_ref-cohen_7-8" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> The partial nephrectomy involves the removal of the affected tissue only, sparing the rest of the kidney, Gerota's fascia and the regional lymph nodes. This allows for more renal preservation as compared to the radical nephrectomy, and this can have positive long term health benefits.<sup id="cite_ref-pn_vs_rn_weight_62-0" class="reference"><a href="#cite_note-pn_vs_rn_weight-62"><span>[</span>62<span>]</span></a></sup> Larger and more complex tumors can also be treated with partial nephrectomy by surgeons with a lot of kidney surgery experience.<sup id="cite_ref-cw_bjui_63-0" class="reference"><a href="#cite_note-cw_bjui-63"><span>[</span>63<span>]</span></a></sup></p>
<p><b>Laparoscopic nephrectomy</b> uses <a href="/wiki/Laparoscopic_surgery" title="Laparoscopic surgery">laparoscopic surgery</a>, with minimally invasive surgical techniques. Commonly referred to as key hole surgery, this surgery does not have the large incisions seen in a classically performed radical or partial nephrectomy, but still successfully removes either all or part of the kidney. Laparoscopic surgery is associated with shorter stays in the hospital and quicker recovery time but there are still risks associated with the surgical procedure.</p>
<p><b>Surgery for metastatic disease:</b> If metastatic disease is present surgical treatment may still a viable option. Radical and partial nephrectomy can still occur, and in some cases if the metastasis is small this can also be surgically removed.<sup id="cite_ref-cohen_7-9" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> This depends on what stage of growth and how far the disease has spread.</p>
<h3><span class="mw-headline" id="Targeted_ablative_therapies">Targeted ablative therapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=23" title="Edit section: Targeted ablative therapies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Targeted <a href="//en.wiktionary.org/wiki/ablative" class="extiw" title="wiktionary:ablative">ablative</a> therapies are also known as <a href="/wiki/Percutaneous" title="Percutaneous">percutaneous</a> ablative therapies. Although the use of laparoscopic surgical techniques for complete nephrectomies has reduced some of the risks associated with surgery,<sup id="cite_ref-Russo2013_64-0" class="reference"><a href="#cite_note-Russo2013-64"><span>[</span>64<span>]</span></a></sup> surgery of any sort in some cases will still not be feasible. For example, the elderly, people already suffering from severe renal dysfunction, or people who have several <a href="/wiki/Comorbidities" title="Comorbidities" class="mw-redirect">comorbidities</a>, surgery of any sort is not warranted.<sup id="cite_ref-Matin2013_65-0" class="reference"><a href="#cite_note-Matin2013-65"><span>[</span>65<span>]</span></a></sup> Instead there are targeted therapies which do not involve the removal of any organs or serious surgery. Rather, these therapies involve the <a href="/wiki/Ablation" title="Ablation">ablation</a> of the tumor or the affected area. Ablative treatments use imaging such as <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">computed tomography</a> (CT) or <a href="/wiki/MRI" title="MRI" class="mw-redirect">magnetic resonance imaging</a> (MRI) to identify the location of the tumors, which ideally are smaller than 3.5&#160;cm and to guide the treatment. However there are some cases where ablation can be used on tumors that are larger.<sup id="cite_ref-Matin2013_65-1" class="reference"><a href="#cite_note-Matin2013-65"><span>[</span>65<span>]</span></a></sup></p>
<p>The two main types of ablation techniques that are used for renal cell carcinoma are <a href="/wiki/Radio_frequency_ablation" title="Radio frequency ablation" class="mw-redirect">radio frequency ablation</a> and <a href="/wiki/Cryoablation" title="Cryoablation">cryoablation</a>.<sup id="cite_ref-Matin2013_65-2" class="reference"><a href="#cite_note-Matin2013-65"><span>[</span>65<span>]</span></a></sup></p>
<p><b>Radio frequency ablation</b> uses an electrode <a href="//en.wiktionary.org/wiki/probe" class="extiw" title="wiktionary:probe">probe</a> which is inserted into the affected tissue, to send radio frequencies to the tissue to generate heat through the friction of water molecules. The heat destroys the tumor tissue.<sup id="cite_ref-cohen_7-10" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> Cell death will generally occur within minutes of being exposed to temperatures above 50&#160;°C.</p>
<p><b>Cryoablation</b> also involves the insertion of a probe into the affected area,<sup id="cite_ref-cohen_7-11" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> however, cold is used to kill the tumor instead of heat. The probe is cooled with chemical fluids which are very cold. The freezing temperatures cause the tumor cells to die by causing <a href="/wiki/Osmotic_dehydration" title="Osmotic dehydration">osmotic dehydration</a>, which pulls the water out of the cell destroying the <a href="/wiki/Enzyme" title="Enzyme">enzyme</a>, <a href="/wiki/Organelle" title="Organelle">organelles</a>, <a href="/wiki/Cell_membrane" title="Cell membrane">cell membrane</a> and freezing the <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a>.<sup id="cite_ref-Matin2013_65-3" class="reference"><a href="#cite_note-Matin2013-65"><span>[</span>65<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Targeted_drug_treatments">Targeted drug treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=24" title="Edit section: Targeted drug treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Immunomodulatory" title="Immunomodulatory" class="mw-redirect">Immunotherapy</a> is a method that activates the person's immune system and uses it to their own advantage. It was developed after observing that in some cases there was spontaneous regression.<sup id="cite_ref-davar_66-0" class="reference"><a href="#cite_note-davar-66"><span>[</span>66<span>]</span></a></sup> That is, the renal cell carcinoma improved with no other therapies. Immunotherapy capitalises on this phenomenon and aims to build up a person's immune response to cancer cells.<sup id="cite_ref-davar_66-1" class="reference"><a href="#cite_note-davar-66"><span>[</span>66<span>]</span></a></sup> Other medications target things such as growth factors that have been shown to promote the growth and spread of tumours.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup> They inhibit the growth factor in order to prevent tumours from forming.<sup id="cite_ref-stroup_68-0" class="reference"><a href="#cite_note-stroup-68"><span>[</span>68<span>]</span></a></sup> There have been many different medications developed and most have only been approved in the last seven or so years.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup></p>
<p>Some of the most recently developed treatments are listed below:<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup></p>
<div class="div-col columns column-count column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
<ul>
<li><a href="/wiki/Nivolumab" title="Nivolumab">Nivolumab</a> in combination with <a href="/wiki/Ipilimumab" title="Ipilimumab">Ipilimumab</a></li>
<li><a href="/wiki/Axitinib" title="Axitinib">Axitinib</a><sup id="cite_ref-71" class="reference"><a href="#cite_note-71"><span>[</span>71<span>]</span></a></sup></li>
<li><a href="/wiki/Sunitinib" title="Sunitinib">Sunitinib</a></li>
<li><a href="/wiki/Bevacizumab" title="Bevacizumab">Bevacizumab</a></li>
<li><a href="/wiki/Sorafenib" title="Sorafenib">Sorafenib</a></li>
<li><a href="/wiki/Pazopanib" title="Pazopanib">Pazopanib</a></li>
<li><a href="/wiki/Carfilzomib" title="Carfilzomib">Carfilzomib</a></li>
<li><a href="/wiki/Everolimus" title="Everolimus">Everolimus</a></li>
<li><a href="/wiki/Interferon-%CE%B1" title="Interferon-α" class="mw-redirect">Interferon-α</a></li>
<li><a href="/wiki/Interleukin_2" title="Interleukin 2">Interleukin-2</a></li>
<li><a href="/wiki/Rapamycin" title="Rapamycin" class="mw-redirect">Sirolimus (Rapamycin)</a></li>
<li><a href="/wiki/Temsirolimus" title="Temsirolimus">Temsirolimus</a></li>
<li><a href="/wiki/Tivozanib" title="Tivozanib">Tivozanib</a></li>
</ul>
</div>
<p>Each of the treatments listed above is slightly different; some only work for a little while and others need to be used in conjunction with other therapies. There are also different side effects and risks associated with different forms of medication. As always, the advice of a health care professional should be sought if considering any of the therapies mentioned.</p>
<h3><span class="mw-headline" id="Chemotherapy">Chemotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=25" title="Edit section: Chemotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Chemotherapy" title="Chemotherapy">Chemotherapy</a> and <a href="/wiki/Radiotherapy" title="Radiotherapy" class="mw-redirect">radiotherapy</a> are not as successful in the case of RCC. RCC is resistant in most cases but there is about a 4-5% success rate sometimes, but this is often short lived with more tumours and growths developing later.<sup id="cite_ref-cohen_7-12" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Vaccine">Vaccine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=26" title="Edit section: Vaccine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Cancer_vaccines" title="Cancer vaccines" class="mw-redirect">Cancer vaccines</a> are being developed but so far have been found to be effective for only certain forms of the RCC.<sup id="cite_ref-cohen_7-13" class="reference"><a href="#cite_note-cohen-7"><span>[</span>7<span>]</span></a></sup> The vaccines are being designed to "prime" the immune system to provide tumour specific immunity.<sup id="cite_ref-davar_66-2" class="reference"><a href="#cite_note-davar-66"><span>[</span>66<span>]</span></a></sup> They are still being developed but the present another treatment possibility.</p>
<h3><span class="mw-headline" id="Adjuvant_and_neoadjuvant_therapy">Adjuvant and neoadjuvant therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=27" title="Edit section: Adjuvant and neoadjuvant therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Adjuvant_therapy" title="Adjuvant therapy">Adjuvant therapy</a>, which refers to therapy given after a primary surgery, has not been found to be beneficial in renal cell cancer.<sup id="cite_ref-nejm_72-0" class="reference"><a href="#cite_note-nejm-72"><span>[</span>72<span>]</span></a></sup> Conversely, <a href="/wiki/Neoadjuvant_therapy" title="Neoadjuvant therapy">neoadjuvant therapy</a> is administered before the intended primary or main treatment. In some cases neoadjuvant therapy has been shown to decrease the size and stage of the RCC to then allow it to be surgically removed.<sup id="cite_ref-stroup_68-1" class="reference"><a href="#cite_note-stroup-68"><span>[</span>68<span>]</span></a></sup> This is a new form of treatment and the effectiveness of this approach is still being assessed in <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a>.</p>
<h2><span class="mw-headline" id="Metastatic_renal_cell_carcinoma">Metastatic renal cell carcinoma</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=28" title="Edit section: Metastatic renal cell carcinoma">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Metastatic renal cell carcinoma (mRCC) is the spread of the primary renal cell carcinoma from the kidney to other organs. 25-30% of people have this metastatic spread by the time they are diagnosed with renal cell carcinoma.<sup id="cite_ref-DoisMissing_73-0" class="reference"><a href="#cite_note-DoisMissing-73"><span>[</span>73<span>]</span></a></sup> This high proportion is explained by the fact that clinical signs are generally mild until the disease progresses to a more severe state.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup> The most common sites for metastasis are the lymph nodes, lung, bones, liver and brain.<sup id="cite_ref-motzer_8-4" class="reference"><a href="#cite_note-motzer-8"><span>[</span>8<span>]</span></a></sup> How this spread affects the staging of the disease and hence prognosis is discussed in the “Diagnosis” and “Prognosis” section.</p>
<p>MRCC has a poor prognosis compared to other cancers although average survival times have increased in the last few years due to treatment advances. Average survival time in 2008 for the metastatic form of the disease was under a year<sup id="cite_ref-DoictrvMissing_75-0" class="reference"><a href="#cite_note-DoictrvMissing-75"><span>[</span>75<span>]</span></a></sup> and by 2013 this improved to an average of 22 months.<sup id="cite_ref-DoiCADbeecMissing_76-0" class="reference"><a href="#cite_note-DoiCADbeecMissing-76"><span>[</span>76<span>]</span></a></sup> Despite this improvement the 5 year survival rate for mRCC remains under 10%<sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup> and 20-25% of suffers remain unresponsive to all treatments and in these cases, the disease has a rapid progression.<sup id="cite_ref-DoiCADbeecMissing_76-1" class="reference"><a href="#cite_note-DoiCADbeecMissing-76"><span>[</span>76<span>]</span></a></sup></p>
<p>The available treatments for RCC discussed in the “Treatment” section are also relevant for the metastatic form of the disease. Options include interleukin-2 which is a standard therapy for advanced renal cell carcinoma.<sup id="cite_ref-nejm_72-1" class="reference"><a href="#cite_note-nejm-72"><span>[</span>72<span>]</span></a></sup> In the past six years, seven new treatments have been approved specifically for mRCC (sunitinib, temsirolimus, bevacizumab, sorafenib, everolimus, pazopanib and axitinib).<sup id="cite_ref-singer_4-1" class="reference"><a href="#cite_note-singer-4"><span>[</span>4<span>]</span></a></sup> These new treatments are based on the fact that renal cell carcinomas are very vascular tumors – they contain a large number of blood vessels. The drugs aim to inhibit the growth of new blood vessels in the tumors, hence slowing growth and in some cases reducing the size of the tumors.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>78<span>]</span></a></sup> Side effects unfortunately are quite common with these treatments and include:<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span>[</span>79<span>]</span></a></sup></p>
<ul>
<li>Gastrointestinal effects - nausea, vomiting, diarrhea, anorexia</li>
<li>Respiratory effects - coughing, dyspnea (difficulty breathing)</li>
<li>Cardiovascular effects -hypertension(high blood pressure)</li>
<li>Neurological effects - intracranial hemorrhage (bleeding into the brain), thrombosis (blood clots) in the brain</li>
<li>Effects on the skin and mucus membranes - rashes, <a href="/wiki/Chemotherapy-induced_acral_erythema" title="Chemotherapy-induced acral erythema">hand-foot syndrome</a>, stomatitis</li>
<li>Bone marrow suppression -resulting in reduced white blood cells, increasing the risk of infections plus anemia and reduced platelets</li>
<li>Renal effects - impaired kidney function</li>
<li>Fatigue.</li>
</ul>
<p>Radiotherapy and chemotherapy are more commonly used in the metastatic form of RCC to target the secondary tumors in the bones, liver, brain and other organs. While not curative, these treatments do provide relief for suffers from symptoms associated with the spread of tumors.<sup id="cite_ref-DoiCADbeecMissing_76-2" class="reference"><a href="#cite_note-DoiCADbeecMissing-76"><span>[</span>76<span>]</span></a></sup> Other potential treatments are still being developed, including tumor vaccines and small molecule inhibitors.<sup id="cite_ref-DoisMissing_73-1" class="reference"><a href="#cite_note-DoisMissing-73"><span>[</span>73<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=29" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">For more details on this topic, see <a href="/wiki/Treatment_and_prognosis_of_renal_cell_carcinoma" title="Treatment and prognosis of renal cell carcinoma">Treatment and prognosis of renal cell carcinoma</a>.</div>
<p>The prognosis for renal cell carcinoma is largely influenced by a variety of factors, including tumour size, degree of invasion and metastasis, histologic type, and nuclear grade.<sup id="cite_ref-rini_21-5" class="reference"><a href="#cite_note-rini-21"><span>[</span>21<span>]</span></a></sup> For metastatic renal cell carcinoma, factors which may present a poor prognosis include a low <a href="/wiki/Performance_status#Karnofsky_scoring" title="Performance status">Karnofsky performance-status score</a> (a standard way of measuring functional impairment in patients with cancer), a low <a href="/wiki/Haemoglobin" title="Haemoglobin" class="mw-redirect">haemoglobin</a> level, a high level of serum lactate dehydrogenase, and a high corrected level of serum calcium.<sup id="cite_ref-Motzer1_80-0" class="reference"><a href="#cite_note-Motzer1-80"><span>[</span>80<span>]</span></a></sup><sup id="cite_ref-Motzer2_81-0" class="reference"><a href="#cite_note-Motzer2-81"><span>[</span>81<span>]</span></a></sup> For non-metastatic cases, the Leibovich scoring algorithm may be used to predict post-operative disease progression.<sup id="cite_ref-Leibovich_82-0" class="reference"><a href="#cite_note-Leibovich-82"><span>[</span>82<span>]</span></a></sup></p>
<p>Renal cell carcinoma is one of the cancers most strongly associated with <a href="/wiki/Paraneoplastic_syndrome" title="Paraneoplastic syndrome">paraneoplastic syndromes</a>, most often due to ectopic hormone production by the tumour. The treatment for these complications of RCC is generally limited beyond treating the underlying cancer.</p>
<p>For those that have tumour recurrence after surgery, the prognosis is generally poor. Renal cell carcinoma does not generally respond to chemotherapy or radiation. Immunotherapy, which attempts to induce the body to attack the remaining cancer cells, has shown promise. Recent trials are testing newer agents, though the current complete remission rate with these approaches is still low, around 12-20% in most series. Most recently, treatment with <a href="/wiki/Tyrosine_kinase_inhibitor" title="Tyrosine kinase inhibitor" class="mw-redirect">tyrosine kinase inhibitors</a> including <a href="/wiki/Nexavar" title="Nexavar" class="mw-redirect">nexavar</a>, <a href="/wiki/Pazopanib" title="Pazopanib">pazopanib</a>, and <a href="/wiki/Rapamycin" title="Rapamycin" class="mw-redirect">rapamycin</a> have shown promise in improving the prognosis for advanced RCC.<sup id="cite_ref-Oosterwijk_83-0" class="reference"><a href="#cite_note-Oosterwijk-83"><span>[</span>83<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=30" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The incidence of the disease varies according to geographic, demographic and, to a lesser extent, hereditary factors. There are some known risk factors, however the significance of other potential risk factors remains more controversial. The incidence of the cancer has been increasing in frequency worldwide at a rate of approximately 2-3% per decade<sup id="cite_ref-DoictrvMissing_75-1" class="reference"><a href="#cite_note-DoictrvMissing-75"><span>[</span>75<span>]</span></a></sup> until the last few years where the number of new cases has stabilised.<sup id="cite_ref-Ljungberg_et_al_2011_14-1" class="reference"><a href="#cite_note-Ljungberg_et_al_2011-14"><span>[</span>14<span>]</span></a></sup></p>
<p>The incidence of RCC varies between sexes, ages, races and geographic location around the world. Men have a higher incidence than women (approximately 1.6:1)<sup id="cite_ref-nejm_72-2" class="reference"><a href="#cite_note-nejm-72"><span>[</span>72<span>]</span></a></sup> and the vast majority are diagnosed after 65 years of age.<sup id="cite_ref-nejm_72-3" class="reference"><a href="#cite_note-nejm-72"><span>[</span>72<span>]</span></a></sup> Asians reportedly have a significantly lower incidence of RCC than whites and while African countries have the lowest reported incidences, African Americans have the highest incidence of the population in the United States.<sup id="cite_ref-Ljungberg_et_al_2011_14-2" class="reference"><a href="#cite_note-Ljungberg_et_al_2011-14"><span>[</span>14<span>]</span></a></sup> Developed countries have a higher incidence than developing countries, with the highest rates found in North America, Europe and Australia / New Zealand<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=31" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Daniel_Sennert" title="Daniel Sennert">Daniel Sennert</a> made the first reference suggesting a <a href="/wiki/Tumour" title="Tumour" class="mw-redirect">tumour</a> arising in the <a href="/wiki/Kidney" title="Kidney">kidney</a> in his text <i>Practicae Medicinae</i>, first published in 1613.<sup id="cite_ref-history_85-0" class="reference"><a href="#cite_note-history-85"><span>[</span>85<span>]</span></a></sup></p>
<p>Miril published the earliest unequivocal case of renal <a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a> in 1810.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup> He described the case of Françoise Levelly, a 35 year old woman, who presented to Brest Civic Hospital on April 6, 1809, supposedly in the late stages of pregnancy.<sup id="cite_ref-history_85-1" class="reference"><a href="#cite_note-history-85"><span>[</span>85<span>]</span></a></sup></p>
<p>Koenig published the first classification of renal tumours based on macroscopic morphology in 1826. Koenig divided the tumors into scirrhous, steatomatous, fungoid and medullary forms.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Hypernephroma_controversy">Hypernephroma controversy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=32" title="Edit section: Hypernephroma controversy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Following the classification of the tumour, researchers attempted to identify the tissue of origin for renal carcinoma.</p>
<p>The <a href="/wiki/Pathogenesis" title="Pathogenesis">pathogenesis</a> of renal epithelial tumours was debated for decades. The debate was initiated by <a href="/wiki/Paul_Grawitz" title="Paul Grawitz">Paul Grawitz</a> when in 1883, he published his observations on the morphology of small, yellow renal <a href="/wiki/Tumors" title="Tumors" class="mw-redirect">tumours</a>. Grawitz concluded that only alveolar tumours were of <a href="/wiki/Adrenal" title="Adrenal" class="mw-redirect">adrenal</a> origin, whereas papillary tumours were derived from <a href="/wiki/Renal" title="Renal" class="mw-redirect">renal</a> tissue.<sup id="cite_ref-history_85-2" class="reference"><a href="#cite_note-history-85"><span>[</span>85<span>]</span></a></sup></p>
<p>In 1893, Paul Sudeck challenged the theory postulated by Grawitz by publishing descriptions of renal tumours in which he identified atypical features within <a href="/wiki/Renal_tubules#Renal_tubule" title="Renal tubules" class="mw-redirect">renal tubules</a> and noted a gradation of these atypical features between the tubules and neighboring <a href="/wiki/Malignant_tumour" title="Malignant tumour" class="mw-redirect">malignant tumour</a>. In 1894, <a href="/wiki/Otto_Lubarsch" title="Otto Lubarsch">Otto Lubarsch</a>, who supported the theory postulated by <a href="/wiki/Paul_Grawitz" title="Paul Grawitz">Grawitz</a> coined the term <i>hypernephroid tumor</i>, which was amended to<i>hypernephroma</i> by <a href="/wiki/Felix_Victor_Birch-Hirschfeld" title="Felix Victor Birch-Hirschfeld">Felix Victor Birch-Hirschfeld</a> to describe these tumours.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88"><span>[</span>88<span>]</span></a></sup></p>
<p>Vigorous criticism of Grawitz was provided by Oskar Stoerk in 1908, who considered the <a href="/wiki/Adrenal" title="Adrenal" class="mw-redirect">adrenal</a> origin of renal tumours to be unproved. Despite the compelling arguments against the theory postulated by Grawitz, the term hypernephroma, with its associated adrenal connotation, persisted in the literature.<sup id="cite_ref-history_85-3" class="reference"><a href="#cite_note-history-85"><span>[</span>85<span>]</span></a></sup></p>
<p>Foot and Humphreys, and Foote et al. introduced the term <i>Renal Celled Carcinoma</i> to emphasize a <a href="/wiki/Renal_tubular#Renal_tubule" title="Renal tubular" class="mw-redirect">renal tubular</a> origin for these <a href="/wiki/Tumors" title="Tumors" class="mw-redirect">tumours</a>. Their designation was slightly altered by Fetter to the now widely accepted term <i>Renal Cell Carcinoma</i>.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup></p>
<p>Convincing evidence to settle the debate was offered by Oberling et al. in 1959 who studied the <a href="/wiki/Ultrastructure" title="Ultrastructure">ultrastructure</a> of clear cells from eight renal <a href="/wiki/Carcinomas" title="Carcinomas" class="mw-redirect">carcinomas</a>. They found that the tumour cell <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a> contained numerous <a href="/wiki/Mitochondria" title="Mitochondria" class="mw-redirect">mitochondria</a> and deposits of <a href="/wiki/Glycogen" title="Glycogen">glycogen</a> and fat. They identified <a href="/wiki/Cytoplasmic_membrane" title="Cytoplasmic membrane" class="mw-redirect">cytoplasmic membranes</a> inserted perpendicularly onto <a href="/wiki/Basement_membrane" title="Basement membrane">basement membrane</a> with occasional cells containing <a href="/wiki/Microvilli" title="Microvilli" class="mw-redirect">microvilli</a> along the free borders. They concluded that these features indicated that the tumours arose from the <a href="/wiki/Epithelial" title="Epithelial" class="mw-redirect">epithelial</a> cells of the <a href="/wiki/Renal_tubule" title="Renal tubule" class="mw-redirect">renal convoluted tubule</a>, thus finally settling one of the most debated issues in <a href="/wiki/Tumour" title="Tumour" class="mw-redirect">tumour</a> pathology.<sup id="cite_ref-history_85-4" class="reference"><a href="#cite_note-history-85"><span>[</span>85<span>]</span></a></sup><sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=33" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Stauffer_syndrome" title="Stauffer syndrome">Stauffer syndrome</a></li>
<li><a href="/wiki/Knudson_hypothesis" title="Knudson hypothesis">Knudson hypothesis</a><sup id="cite_ref-Valladares2008_91-0" class="reference"><a href="#cite_note-Valladares2008-91"><span>[</span>91<span>]</span></a></sup></li>
<li><a href="/wiki/Interleukin-2" title="Interleukin-2" class="mw-redirect">Interleukin-2</a></li>
<li><a href="/wiki/Kidney_cancer" title="Kidney cancer">Kidney cancer</a></li>
<li><a href="/wiki/Rapamycin" title="Rapamycin" class="mw-redirect">Rapamycin</a></li>
<li><a href="/wiki/Vinblastine" title="Vinblastine">Vinblastine</a></li>
<li><a href="/wiki/Dysuria" title="Dysuria">Dysuria</a></li>
<li><a href="/wiki/Interferon" title="Interferon">Interferon</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit&amp;section=34" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-MSR-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-MSR_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MSR_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MSR_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MSR_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MSR_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-MSR_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-MSR_1-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Curti, B; Jana, BRP; Javeed, M; Makhoul, I; Sachdeva, K; Hu, W; Perry, M; Talavera, F (26 February 2014). Harris, JE, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/281340-overview#showall">"Renal Cell Carcinoma"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">7 March</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+Cell+Carcinoma&amp;rft.au=Curti%2C+B&amp;rft.aufirst=B&amp;rft.au=Hu%2C+W&amp;rft.au=Jana%2C+BRP&amp;rft.au=Javeed%2C+M&amp;rft.aulast=Curti&amp;rft.au=Makhoul%2C+I&amp;rft.au=Perry%2C+M&amp;rft.au=Sachdeva%2C+K&amp;rft.au=Talavera%2C+F&amp;rft.date=26+February+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F281340-overview%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-r-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-r_2-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rini BI, Rathmell WK, Godley P; Rathmell; Godley (May 2008). "Renal cell carcinoma". <i>Curr Opin Oncol</i> <b>20</b> (3): 300–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FCCO.0b013e3282f9782b">10.1097/CCO.0b013e3282f9782b</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18391630">18391630</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma&amp;rft.au=Godley&amp;rft.aulast=Rini+BI%2C+Rathmell+WK%2C+Godley+P&amp;rft.au=Rathmell&amp;rft.au=Rini+BI%2C+Rathmell+WK%2C+Godley+P&amp;rft.date=May+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FCCO.0b013e3282f9782b&amp;rft_id=info%3Apmid%2F18391630&amp;rft.issue=3&amp;rft.jtitle=Curr+Opin+Oncol&amp;rft.pages=300-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.nhs.uk/conditions/Cancer-of-the-kidney/Pages/Introduction.aspx">http://www.nhs.uk/conditions/Cancer-of-the-kidney/Pages/Introduction.aspx</a></span></li>
<li id="cite_note-singer-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-singer_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-singer_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Singer, Eric A.; Gupta, Gopal N.; Marchalik, Daniel; Srinivasan, Ramaprasad (2013). "Evolving therapeutic targets in renal cell carcinoma". <i>Current Opinion in Oncology</i>: 1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FCCO.0b013e32835fc857">10.1097/CCO.0b013e32835fc857</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Evolving+therapeutic+targets+in+renal+cell+carcinoma&amp;rft.aufirst=Eric+A.&amp;rft.au=Gupta%2C+Gopal+N.&amp;rft.aulast=Singer&amp;rft.au=Marchalik%2C+Daniel&amp;rft.au=Singer%2C+Eric+A.&amp;rft.au=Srinivasan%2C+Ramaprasad&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FCCO.0b013e32835fc857&amp;rft.jtitle=Current+Opinion+in+Oncology&amp;rft.pages=1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-path-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-path_5-0">^</a></b></span> <span class="reference-text"><span class="citation book">Fausto, V; Abbas, A; Fausto, N (2004). <i>Robbins and Cotran Pathologic Basis of disease.</i> (7th ed.). Philadelphia, PA: Elsevier/Saunders. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0721601878" title="Special:BookSources/978-0721601878">978-0721601878</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.au=Fausto%2C+V%3B+Abbas%2C+A%3B+Fausto%2C+N&amp;rft.aufirst=V%3B+Abbas%2C+A%3B+Fausto%2C+N&amp;rft.aulast=Fausto&amp;rft.btitle=Robbins+and+Cotran+Pathologic+Basis+of+disease.&amp;rft.date=2004&amp;rft.edition=7th&amp;rft.genre=book&amp;rft.isbn=978-0721601878&amp;rft.place=Philadelphia%2C+PA&amp;rft.pub=Elsevier%2FSaunders&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MM-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-MM_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MM_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MM_6-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Master, VA (November 2013). <a rel="nofollow" class="external text" href="http://www.merckmanuals.com/professional/genitourinary_disorders/genitourinary_cancer/renal_cell_carcinoma.html">"Renal Cell Carcinoma"</a>. <i>Merck Manual Professional</i>. Merck Sharp &amp; Dohme Corp<span class="reference-accessdate">. Retrieved <span class="nowrap">7 March</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+Cell+Carcinoma&amp;rft.aulast=Master%2C+VA&amp;rft.au=Master%2C+VA&amp;rft.date=November+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.merckmanuals.com%2Fprofessional%2Fgenitourinary_disorders%2Fgenitourinary_cancer%2Frenal_cell_carcinoma.html&amp;rft.jtitle=Merck+Manual+Professional&amp;rft.pub=Merck+Sharp+%26+Dohme+Corp.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-cohen-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-cohen_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cohen_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-cohen_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-cohen_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-cohen_7-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-cohen_7-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-cohen_7-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-cohen_7-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-cohen_7-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-cohen_7-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-cohen_7-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-cohen_7-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-cohen_7-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-cohen_7-13"><sup><i><b>n</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Cohen, Herbert T.; McGovern, Francis J. (2005). "Renal-Cell Carcinoma". <i>New England Journal of Medicine</i> <b>353</b> (23): 2477–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra043172">10.1056/NEJMra043172</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16339096">16339096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal-Cell+Carcinoma&amp;rft.au=Cohen%2C+Herbert+T.&amp;rft.aufirst=Herbert+T.&amp;rft.aulast=Cohen&amp;rft.au=McGovern%2C+Francis+J.&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra043172&amp;rft_id=info%3Apmid%2F16339096&amp;rft.issue=23&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=2477-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=353" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-motzer-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-motzer_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-motzer_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-motzer_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-motzer_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-motzer_8-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Motzer, Robert J.; Bander, Neil H.; Nanus, David M. (1996). "Renal-Cell Carcinoma". <i>New England Journal of Medicine</i> <b>335</b> (12): 865–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199609193351207">10.1056/NEJM199609193351207</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8778606">8778606</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal-Cell+Carcinoma&amp;rft.au=Bander%2C+Neil+H.&amp;rft.aufirst=Robert+J.&amp;rft.aulast=Motzer&amp;rft.au=Motzer%2C+Robert+J.&amp;rft.au=Nanus%2C+David+M.&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199609193351207&amp;rft_id=info%3Apmid%2F8778606&amp;rft.issue=12&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=865-75&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=335" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-kim-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-kim_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-kim_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-kim_9-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Kim, Hyung L.; Belldegrun, Arie S.; Freitas, Danielo G.; Bui, Matthew H.T.; Han, KEN-RYU; Dorey, Frederick J.; Figlin, Robert A. (2003). "Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis". <i>The Journal of Urology</i> <b>170</b> (5): 1742–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.ju.0000092764.81308.6a">10.1097/01.ju.0000092764.81308.6a</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14532767">14532767</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Paraneoplastic+Signs+and+Symptoms+of+Renal+Cell+Carcinoma%3A+Implications+for+Prognosis&amp;rft.au=Belldegrun%2C+Arie+S.&amp;rft.au=Bui%2C+Matthew+H.T.&amp;rft.au=Dorey%2C+Frederick+J.&amp;rft.au=Figlin%2C+Robert+A.&amp;rft.aufirst=Hyung+L.&amp;rft.au=Freitas%2C+Danielo+G.&amp;rft.au=Han%2C+KEN-RYU&amp;rft.au=Kim%2C+Hyung+L.&amp;rft.aulast=Kim&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.ju.0000092764.81308.6a&amp;rft_id=info%3Apmid%2F14532767&amp;rft.issue=5&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=1742-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=170" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Birkhauser2013-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Birkhauser2013_10-0">^</a></b></span> <span class="reference-text"><span class="citation book">Birkhauser; Kroeger, Pantuck (2013). "Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors". <i>Renal Cell Carcinoma Clinical Management</i>. Humana Pr Inc. pp.&#160;3–22. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Etiology+of+Renal+Cell+Carcinoma%3A+Incidence%2C+Demographics%2C+and+Environmental+Factors&amp;rft.au=Birkhauser&amp;rft.au=Kroeger%2C+Pantuck&amp;rft.aulast=Birkhauser&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=3-22&amp;rft.pub=Humana+Pr+Inc&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lane-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lane_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lane_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lane_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Lane, Brian R. (2013). "Prognostic Factors for Localized Renal Cell Carcinoma". <i>Renal Cell Carcinoma</i>. pp.&#160;83–102. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2F978-1-62703-062-5_5">10.1007/978-1-62703-062-5_5</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Prognostic+Factors+for+Localized+Renal+Cell+Carcinoma&amp;rft.aufirst=Brian+R.&amp;rft.au=Lane%2C+Brian+R.&amp;rft.aulast=Lane&amp;rft.btitle=Renal+Cell+Carcinoma&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-62703-062-5_5&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=83-102&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-metz-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-metz_12-0">^</a></b></span> <span class="reference-text"><span class="citation book">Metz; Davis (2013). "Palliative and Supportive Care for Renal Cancer". <i>Renal Cell Carcinoma Clinical Management</i>. Humana. pp.&#160;339–348. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Palliative+and+Supportive+Care+for+Renal+Cancer&amp;rft.au=Davis&amp;rft.aulast=Metz&amp;rft.au=Metz&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management.&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=339-348&amp;rft.pub=Humana&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Häggström, Christel; Rapp, Kilian; Stocks, Tanja; Manjer, Jonas; Bjørge, Tone; Ulmer, Hanno; Engeland, Anders; Almqvist, Martin; Concin, Hans; Selmer, R; Ljungberg, B; Tretli, S; Nagel, G; Hallmans, G; Jonsson, H; Stattin, P (2013). Miller, Todd W, ed. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585341">"Metabolic Factors Associated with Risk of Renal Cell Carcinoma"</a>. <i>PLoS ONE</i> <b>8</b> (2): e57475. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/2013PLoSO...857475H">2013PLoSO...857475H</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1371%2Fjournal.pone.0057475">10.1371/journal.pone.0057475</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3585341">3585341</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23468995">23468995</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Metabolic+Factors+Associated+with+Risk+of+Renal+Cell+Carcinoma&amp;rft.au=Almqvist%2C+Martin&amp;rft.au=Bj%C3%B8rge%2C+Tone&amp;rft.au=Concin%2C+Hans&amp;rft.au=Engeland%2C+Anders&amp;rft.aufirst=Christel&amp;rft.au=Hallmans%2C+G&amp;rft.au=H%C3%A4ggstr%C3%B6m%2C+Christel&amp;rft.au=Jonsson%2C+H&amp;rft.aulast=H%C3%A4ggstr%C3%B6m&amp;rft.au=Ljungberg%2C+B&amp;rft.au=Manjer%2C+Jonas&amp;rft.au=Nagel%2C+G&amp;rft.au=Rapp%2C+Kilian&amp;rft.au=Selmer%2C+R&amp;rft.au=Stattin%2C+P&amp;rft.au=Stocks%2C+Tanja&amp;rft.au=Tretli%2C+S&amp;rft.au=Ulmer%2C+Hanno&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3585341&amp;rft_id=info%3Abibcode%2F2013PLoSO...857475H&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0057475&amp;rft_id=info%3Apmc%2F3585341&amp;rft_id=info%3Apmid%2F23468995&amp;rft.issue=2&amp;rft.jtitle=PLoS+ONE&amp;rft.pages=e57475&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ljungberg_et_al_2011-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ljungberg_et_al_2011_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ljungberg_et_al_2011_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ljungberg_et_al_2011_14-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ljungberg, Börje; Campbell, Steven C.; Choi, Han Yong; Jacqmin, Didier; Lee, Jung Eun; Weikert, Steffen; Kiemeney, Lambertus A. (2011). "The Epidemiology of Renal Cell Carcinoma". <i>European Urology</i> <b>60</b> (4): 615–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.eururo.2011.06.049">10.1016/j.eururo.2011.06.049</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21741761">21741761</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=The+Epidemiology+of+Renal+Cell+Carcinoma&amp;rft.au=Campbell%2C+Steven+C.&amp;rft.au=Choi%2C+Han+Yong&amp;rft.aufirst=B%C3%B6rje&amp;rft.au=Jacqmin%2C+Didier&amp;rft.au=Kiemeney%2C+Lambertus+A.&amp;rft.aulast=Ljungberg&amp;rft.au=Lee%2C+Jung+Eun&amp;rft.au=Ljungberg%2C+B%C3%B6rje&amp;rft.au=Weikert%2C+Steffen&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2011.06.049&amp;rft_id=info%3Apmid%2F21741761&amp;rft.issue=4&amp;rft.jtitle=European+Urology&amp;rft.pages=615-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Dhôte, R.; Pellicer-Coeuret, M.; Thiounn, N.; Debré, B.; Vidal-Trecan, G. (2007). "Risk factors for adult renal cell carcinoma: A systematic review and implications for prevention". <i>BJU International</i> <b>86</b> (1): 20–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1464-410x.2000.00708.x">10.1046/j.1464-410x.2000.00708.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10886077">10886077</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Risk+factors+for+adult+renal+cell+carcinoma%3A+A+systematic+review+and+implications+for+prevention&amp;rft.au=Debr%C3%A9%2C+B.&amp;rft.au=Dh%C3%B4te%2C+R.&amp;rft.aufirst=R.&amp;rft.aulast=Dh%C3%B4te&amp;rft.au=Pellicer-Coeuret%2C+M.&amp;rft.au=Thiounn%2C+N.&amp;rft.au=Vidal-Trecan%2C+G.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1464-410x.2000.00708.x&amp;rft_id=info%3Apmid%2F10886077&amp;rft.issue=1&amp;rft.jtitle=BJU+International&amp;rft.pages=20-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Boffetta, P.; Fontana, L.; Stewart, P.; Zaridze, D.; Szeszenia-Dabrowska, N.; Janout, V.; Bencko, V.; Foretova, L.; Jinga, V.; Matveev, V.; Kollarova, H.; Ferro, G.; Chow, W.-H.; Rothman, N.; Van Bemmel, D.; Karami, S.; Brennan, P.; Moore, L. E. (2011). "Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: A case-control study from Central and Eastern Europe". <i>Occupational and Environmental Medicine</i> <b>68</b> (10): 723–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Foem.2010.056341">10.1136/oem.2010.056341</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21217163">21217163</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Occupational+exposure+to+arsenic%2C+cadmium%2C+chromium%2C+lead+and+nickel%2C+and+renal+cell+carcinoma%3A+A+case-control+study+from+Central+and+Eastern+Europe&amp;rft.au=Bencko%2C+V.&amp;rft.au=Boffetta%2C+P.&amp;rft.au=Brennan%2C+P.&amp;rft.au=Chow%2C+W.-H.&amp;rft.au=Ferro%2C+G.&amp;rft.aufirst=P.&amp;rft.au=Fontana%2C+L.&amp;rft.au=Foretova%2C+L.&amp;rft.au=Janout%2C+V.&amp;rft.au=Jinga%2C+V.&amp;rft.au=Karami%2C+S.&amp;rft.au=Kollarova%2C+H.&amp;rft.aulast=Boffetta&amp;rft.au=Matveev%2C+V.&amp;rft.au=Moore%2C+L.+E.&amp;rft.au=Rothman%2C+N.&amp;rft.au=Stewart%2C+P.&amp;rft.au=Szeszenia-Dabrowska%2C+N.&amp;rft.au=Van+Bemmel%2C+D.&amp;rft.au=Zaridze%2C+D.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Foem.2010.056341&amp;rft_id=info%3Apmid%2F21217163&amp;rft.issue=10&amp;rft.jtitle=Occupational+and+Environmental+Medicine&amp;rft.pages=723-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Cho, Eunyoung; Curhan, G; Hankinson, SE; Kantoff, P; Atkins, MB; Stampfer, M; Choueiri, TK (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3691864">"Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer"</a>. <i>Archives of Internal Medicine</i> <b>171</b> (16): 1487–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinternmed.2011.356">10.1001/archinternmed.2011.356</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3691864">3691864</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21911634">21911634</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Prospective+Evaluation+of+Analgesic+Use+and+Risk+of+Renal+Cell+Cancer&amp;rft.au=Atkins%2C+MB&amp;rft.au=Cho%2C+Eunyoung&amp;rft.au=Choueiri%2C+TK&amp;rft.au=Curhan%2C+G&amp;rft.aufirst=Eunyoung&amp;rft.au=Hankinson%2C+SE&amp;rft.au=Kantoff%2C+P&amp;rft.aulast=Cho&amp;rft.au=Stampfer%2C+M&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3691864&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2011.356&amp;rft_id=info%3Apmc%2F3691864&amp;rft_id=info%3Apmid%2F21911634&amp;rft.issue=16&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.pages=1487-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=171" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Zucchetto, Antonella; Talamini, Renato; Dal Maso, Luigino; Negri, Eva; Polesel, Jerry; Ramazzotti, Valerio; Montella, Maurizio; Canzonieri, Vincenzo; Serraino, Diego; La Vecchia, Carlo; Franceschi, Silvia (2008). "Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer". <i>International Journal of Cancer</i> <b>123</b> (9): 2213–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fijc.23750">10.1002/ijc.23750</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18711701">18711701</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Reproductive%2C+menstrual%2C+and+other+hormone-related+factors+and+risk+of+renal+cell+cancer&amp;rft.au=Canzonieri%2C+Vincenzo&amp;rft.au=Dal+Maso%2C+Luigino&amp;rft.aufirst=Antonella&amp;rft.au=Franceschi%2C+Silvia&amp;rft.aulast=Zucchetto&amp;rft.au=La+Vecchia%2C+Carlo&amp;rft.au=Montella%2C+Maurizio&amp;rft.au=Negri%2C+Eva&amp;rft.au=Polesel%2C+Jerry&amp;rft.au=Ramazzotti%2C+Valerio&amp;rft.au=Serraino%2C+Diego&amp;rft.au=Talamini%2C+Renato&amp;rft.au=Zucchetto%2C+Antonella&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.23750&amp;rft_id=info%3Apmid%2F18711701&amp;rft.issue=9&amp;rft.jtitle=International+Journal+of+Cancer&amp;rft.pages=2213-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=123" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lipworth2009-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lipworth2009_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lipworth, L; Tarone, RE; Lund, L; McLaughlin, JK (2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2943168">"Epidemiologic characteristics and risk factors for renal cell cancer"</a>. <i>Clinical epidemiology</i> <b>1</b>: 33–43. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2943168">2943168</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20865085">20865085</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Epidemiologic+characteristics+and+risk+factors+for+renal+cell+cancer&amp;rft.aufirst=L&amp;rft.aulast=Lipworth&amp;rft.au=Lipworth%2C+L&amp;rft.au=Lund%2C+L&amp;rft.au=McLaughlin%2C+JK&amp;rft.au=Tarone%2C+RE&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2943168&amp;rft_id=info%3Apmc%2F2943168&amp;rft_id=info%3Apmid%2F20865085&amp;rft.jtitle=Clinical+epidemiology&amp;rft.pages=33-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pavlovich2004-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pavlovich2004_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pavlovich, Christian P.; Schmidt, Laura S. (2004). "Searching for the hereditary causes of renal-cell carcinoma". <i>Nature Reviews Cancer</i> <b>4</b> (5): 381–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrc1364">10.1038/nrc1364</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15122209">15122209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Searching+for+the+hereditary+causes+of+renal-cell+carcinoma&amp;rft.aufirst=Christian+P.&amp;rft.aulast=Pavlovich&amp;rft.au=Pavlovich%2C+Christian+P.&amp;rft.au=Schmidt%2C+Laura+S.&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1364&amp;rft_id=info%3Apmid%2F15122209&amp;rft.issue=5&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.pages=381-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-rini-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-rini_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-rini_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-rini_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-rini_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-rini_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-rini_21-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rini, Brian I; Campbell, Steven C; Escudier, Bernard (2009). "Renal cell carcinoma". <i>The Lancet</i> <b>373</b> (9669): 1119. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2809%2960229-4">10.1016/S0140-6736(09)60229-4</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma&amp;rft.au=Campbell%2C+Steven+C&amp;rft.au=Escudier%2C+Bernard&amp;rft.aufirst=Brian+I&amp;rft.aulast=Rini&amp;rft.au=Rini%2C+Brian+I&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2809%2960229-4&amp;rft.issue=9669&amp;rft.jtitle=The+Lancet&amp;rft.pages=1119&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=373" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Baldewijns2008-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-Baldewijns2008_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Baldewijns, Marcella M.L.; Van Vlodrop, Iris J.H.; Schouten, Leo J.; Soetekouw, Patricia M.M.B.; De Bruïne, Adriaan P.; Van Engeland, Manon (2008). "Genetics and epigenetics of renal cell cancer". <i>Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</i> <b>1785</b> (2): 133. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.bbcan.2007.12.002">10.1016/j.bbcan.2007.12.002</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Genetics+and+epigenetics+of+renal+cell+cancer&amp;rft.au=Baldewijns%2C+Marcella+M.L.&amp;rft.au=De+Bru%C3%AFne%2C+Adriaan+P.&amp;rft.aufirst=Marcella+M.L.&amp;rft.aulast=Baldewijns&amp;rft.au=Schouten%2C+Leo+J.&amp;rft.au=Soetekouw%2C+Patricia+M.M.B.&amp;rft.au=Van+Engeland%2C+Manon&amp;rft.au=Van+Vlodrop%2C+Iris+J.H.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbcan.2007.12.002&amp;rft.issue=2&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Reviews+on+Cancer&amp;rft.pages=133&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1785" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tjaden-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tjaden_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tjaden, Christin; Werner, Jens; Buechler, Markus W.; Hackert, Thilo (2011). "Reactive Hypertrophy of an Accessory Spleen Mimicking Tumour Recurrence of Metastatic Renal Cell Carcinoma". <i>Asian Journal of Surgery</i> <b>34</b> (1): 50–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1015-9584%2811%2960019-5">10.1016/S1015-9584(11)60019-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21515214">21515214</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Reactive+Hypertrophy+of+an+Accessory+Spleen+Mimicking+Tumour+Recurrence+of+Metastatic+Renal+Cell+Carcinoma&amp;rft.au=Buechler%2C+Markus+W.&amp;rft.aufirst=Christin&amp;rft.au=Hackert%2C+Thilo&amp;rft.aulast=Tjaden&amp;rft.au=Tjaden%2C+Christin&amp;rft.au=Werner%2C+Jens&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1015-9584%2811%2960019-5&amp;rft_id=info%3Apmid%2F21515214&amp;rft.issue=1&amp;rft.jtitle=Asian+Journal+of+Surgery&amp;rft.pages=50-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-agabegi2nd-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-agabegi2nd_24-0">^</a></b></span> <span class="reference-text"><span class="citation book">Elizabeth D Agabegi; Agabegi, Steven S. (2008). <i>Step-Up to Medicine (Step-Up Series)</i>. Hagerstwon, MD: Lippincott Williams &amp; Wilkins. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7153-6" title="Special:BookSources/0-7817-7153-6">0-7817-7153-6</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.au=Elizabeth+D+Agabegi%3B+Agabegi%2C+Steven+S.&amp;rft.aulast=Elizabeth+D+Agabegi%3B+Agabegi%2C+Steven+S.&amp;rft.btitle=Step-Up+to+Medicine+%28Step-Up+Series%29&amp;rft.date=2008&amp;rft.genre=book&amp;rft.isbn=0-7817-7153-6&amp;rft.place=Hagerstwon%2C+MD&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Catto, James W.F.; Shariat, Shahrokh F. (2013). "The Changing Face of Renal Cell Carcinoma: The Impact of Systematic Genetic Sequencing on Our Understanding of This Tumor's Biology". <i>European Urology</i> <b>63</b> (5): 855–7; discussion 857–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.eururo.2012.09.049">10.1016/j.eururo.2012.09.049</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23026395">23026395</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=The+Changing+Face+of+Renal+Cell+Carcinoma%3A+The+Impact+of+Systematic+Genetic+Sequencing+on+Our+Understanding+of+This+Tumor%27s+Biology&amp;rft.au=Catto%2C+James+W.F.&amp;rft.aufirst=James+W.F.&amp;rft.aulast=Catto&amp;rft.au=Shariat%2C+Shahrokh+F.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2012.09.049&amp;rft_id=info%3Apmid%2F23026395&amp;rft.issue=5&amp;rft.jtitle=European+Urology&amp;rft.pages=855-7%3B+discussion+857-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-zhou-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-zhou_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-zhou_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-zhou_26-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-zhou_26-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-zhou_26-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-zhou_26-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-zhou_26-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Zhou, Ming; He, Huiying (2013). "Pathology of Renal Cell Carcinoma". <i>Renal Cell Carcinoma</i>. pp.&#160;23–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2F978-1-62703-062-5_2">10.1007/978-1-62703-062-5_2</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Pathology+of+Renal+Cell+Carcinoma&amp;rft.aufirst=Ming&amp;rft.au=He%2C+Huiying&amp;rft.aulast=Zhou&amp;rft.au=Zhou%2C+Ming&amp;rft.btitle=Renal+Cell+Carcinoma&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-62703-062-5_2&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=23-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo; Kirkali, Ziya (2006). "2004 WHO Classification of the Renal Tumors of the Adults". <i>European Urology</i> <b>49</b> (5): 798–805. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.eururo.2005.11.035">10.1016/j.eururo.2005.11.035</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16442207">16442207</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=2004+WHO+Classification+of+the+Renal+Tumors+of+the+Adults&amp;rft.aufirst=Antonio&amp;rft.au=Kirkali%2C+Ziya&amp;rft.aulast=Lopez-Beltran&amp;rft.au=Lopez-Beltran%2C+Antonio&amp;rft.au=Montironi%2C+Rodolfo&amp;rft.au=Scarpelli%2C+Marina&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2005.11.035&amp;rft_id=info%3Apmid%2F16442207&amp;rft.issue=5&amp;rft.jtitle=European+Urology&amp;rft.pages=798-805&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Hagenkord, Jill M; Parwani, Anil V; Lyons-Weiler, Maureen A; Alvarez, Karla; Amato, Robert; Gatalica, Zoran; Gonzalez-Berjon, Jose M; Peterson, Leif; Dhir, Rajiv; Monzon, Federico A (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2588560">"Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors"</a>. <i>Diagnostic Pathology</i> <b>3</b>: 44. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1746-1596-3-44">10.1186/1746-1596-3-44</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2588560">2588560</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18990225">18990225</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Virtual+karyotyping+with+SNP+microarrays+reduces+uncertainty+in+the+diagnosis+of+renal+epithelial+tumors&amp;rft.au=Alvarez%2C+Karla&amp;rft.au=Amato%2C+Robert&amp;rft.au=Dhir%2C+Rajiv&amp;rft.aufirst=Jill+M&amp;rft.au=Gatalica%2C+Zoran&amp;rft.au=Gonzalez-Berjon%2C+Jose+M&amp;rft.au=Hagenkord%2C+Jill+M&amp;rft.aulast=Hagenkord&amp;rft.au=Lyons-Weiler%2C+Maureen+A&amp;rft.au=Monzon%2C+Federico+A&amp;rft.au=Parwani%2C+Anil+V&amp;rft.au=Peterson%2C+Leif&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2588560&amp;rft_id=info%3Adoi%2F10.1186%2F1746-1596-3-44&amp;rft_id=info%3Apmc%2F2588560&amp;rft_id=info%3Apmid%2F18990225&amp;rft.jtitle=Diagnostic+Pathology&amp;rft.pages=44&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Monzon, Federico A; Hagenkord, Jill M; Lyons-Weiler, Maureen A; Balani, Jyoti P; Parwani, Anil V; Sciulli, Christin M; Li, Jia; Chandran, Uma R; Bastacky, Sheldon I; Dhir, Rajiv (2008). "Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors". <i>Modern Pathology</i> <b>21</b> (5): 599–608. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fmodpathol.2008.20">10.1038/modpathol.2008.20</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18246049">18246049</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Whole+genome+SNP+arrays+as+a+potential+diagnostic+tool+for+the+detection+of+characteristic+chromosomal+aberrations+in+renal+epithelial+tumors&amp;rft.au=Balani%2C+Jyoti+P&amp;rft.au=Bastacky%2C+Sheldon+I&amp;rft.au=Chandran%2C+Uma+R&amp;rft.au=Dhir%2C+Rajiv&amp;rft.aufirst=Federico+A&amp;rft.au=Hagenkord%2C+Jill+M&amp;rft.aulast=Monzon&amp;rft.au=Li%2C+Jia&amp;rft.au=Lyons-Weiler%2C+Maureen+A&amp;rft.au=Monzon%2C+Federico+A&amp;rft.au=Parwani%2C+Anil+V&amp;rft.au=Sciulli%2C+Christin+M&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.2008.20&amp;rft_id=info%3Apmid%2F18246049&amp;rft.issue=5&amp;rft.jtitle=Modern+Pathology&amp;rft.pages=599-608&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Lyons-Weiler M, Hagenkord J, Sciulli C, Dhir R, Monzon FA; Hagenkord; Sciulli; Dhir; Monzon (March 2008). "Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues". <i>Diagn. Mol. Pathol.</i> <b>17</b> (1): 3–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FPDM.0b013e31815aca30">10.1097/PDM.0b013e31815aca30</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18303412">18303412</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Optimization+of+the+Affymetrix+GeneChip+Mapping+10K+2.0+Assay+for+routine+clinical+use+on+formalin-fixed+paraffin-embedded+tissues&amp;rft.au=Dhir&amp;rft.au=Hagenkord&amp;rft.aulast=Lyons-Weiler+M%2C+Hagenkord+J%2C+Sciulli+C%2C+Dhir+R%2C+Monzon+FA&amp;rft.au=Lyons-Weiler+M%2C+Hagenkord+J%2C+Sciulli+C%2C+Dhir+R%2C+Monzon+FA&amp;rft.au=Monzon&amp;rft.au=Sciulli&amp;rft.date=March+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FPDM.0b013e31815aca30&amp;rft_id=info%3Apmid%2F18303412&amp;rft.issue=1&amp;rft.jtitle=Diagn.+Mol.+Pathol.&amp;rft.pages=3-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid24364021-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid24364021_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid24364021_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid24364021_31-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Crumley, S. M.; Divatia, M; Truong, L; Shen, S; Ayala, A. G.; Ro, J. Y. (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3868710">"Renal cell carcinoma: Evolving and emerging subtypes"</a>. <i>World journal of clinical cases</i> <b>1</b> (9): 262–275. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.12998/wjcc.v1.i9.262 (inactive 2015-01-09). <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3868710">3868710</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24364021">24364021</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma%3A+Evolving+and+emerging+subtypes&amp;rft.au=Ayala%2C+A.+G.&amp;rft.au=Crumley%2C+S.+M.&amp;rft.au=Divatia%2C+M&amp;rft.aufirst=S.+M.&amp;rft.aulast=Crumley&amp;rft.au=Ro%2C+J.+Y.&amp;rft.au=Shen%2C+S&amp;rft.au=Truong%2C+L&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3868710&amp;rft_id=info%3Adoi%2F10.12998%2Fwjcc.v1.i9.262&amp;rft_id=info%3Apmc%2F3868710&amp;rft_id=info%3Apmid%2F24364021&amp;rft.issue=9&amp;rft.jtitle=World+journal+of+clinical+cases&amp;rft.pages=262-275&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/24364021&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Rohan, S. M.; Xiao, Y; Liang, Y; Dudas, M. E.; Al-Ahmadie, H. A.; Fine, S. W.; Gopalan, A; Reuter, V. E.; Rosenblum, M. K.; Russo, P; Tickoo, S. K. (2011). "Clear-cell papillary renal cell carcinoma: Molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins". <i>Modern Pathology</i> <b>24</b> (9): 1207–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fmodpathol.2011.80">10.1038/modpathol.2011.80</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21602815">21602815</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Clear-cell+papillary+renal+cell+carcinoma%3A+Molecular+and+immunohistochemical+analysis+with+emphasis+on+the+von+Hippel-Lindau+gene+and+hypoxia-inducible+factor+pathway-related+proteins&amp;rft.au=Al-Ahmadie%2C+H.+A.&amp;rft.au=Dudas%2C+M.+E.&amp;rft.au=Fine%2C+S.+W.&amp;rft.aufirst=S.+M.&amp;rft.au=Gopalan%2C+A&amp;rft.aulast=Rohan&amp;rft.au=Liang%2C+Y&amp;rft.au=Reuter%2C+V.+E.&amp;rft.au=Rohan%2C+S.+M.&amp;rft.au=Rosenblum%2C+M.+K.&amp;rft.au=Russo%2C+P&amp;rft.au=Tickoo%2C+S.+K.&amp;rft.au=Xiao%2C+Y&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.2011.80&amp;rft_id=info%3Apmid%2F21602815&amp;rft.issue=9&amp;rft.jtitle=Modern+Pathology&amp;rft.pages=1207-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span><span class="plainlinks noprint" style="font-size:smaller">&#160;<a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cite_pmid/21602815&amp;action=edit&amp;editintro=Template:Cite_pmid/editintro2">edit</a></span></span></li>
<li id="cite_note-Wood-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wood_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wood, Laura S. (30 November 2009). "Renal Cell Carcinoma". <i>Clinical Journal of Oncology Nursing</i> <b>13</b>: 3–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1188%2F09.CJON.S2.3-7">10.1188/09.CJON.S2.3-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19948453">19948453</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+Cell+Carcinoma&amp;rft.aufirst=Laura+S.&amp;rft.aulast=Wood&amp;rft.au=Wood%2C+Laura+S.&amp;rft.date=30+November+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1188%2F09.CJON.S2.3-7&amp;rft_id=info%3Apmid%2F19948453&amp;rft.jtitle=Clinical+Journal+of+Oncology+Nursing&amp;rft.pages=3-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Bonn, Dorothy (31 Jan 2004). "Urine test for renal-cell carcinoma". <i>The Lancet Oncology</i> <b>5</b> (2): 72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1470-2045%2804%2901368-3">10.1016/S1470-2045(04)01368-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14974475">14974475</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Urine+test+for+renal-cell+carcinoma&amp;rft.au=Bonn%2C+Dorothy&amp;rft.aufirst=Dorothy&amp;rft.aulast=Bonn&amp;rft.date=31+Jan+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2804%2901368-3&amp;rft_id=info%3Apmid%2F14974475&amp;rft.issue=2&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.pages=72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Johann-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Johann_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Johann, Donald J.; Wei, Bih-Rong; Prieto, Darue A.; Chan, King C.; Ye, Xiaying; Valera, Vladimir A.; Simpson, R. Mark; Rudnick, Paul A.; Xiao, Zhen; Issaq, Haleem J.; Linehan, W. Marston; Stein, Stephen E.; Veenstra, Timothy D.; Blonder, Josip (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3251958">"Combined Blood/Tissue Analysis for Cancer Biomarker Discovery: Application to Renal Cell Carcinoma"</a>. <i>Analytical Chemistry</i> <b>82</b> (5): 1584–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1021%2Fac902204k">10.1021/ac902204k</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3251958">3251958</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20121140">20121140</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Combined+Blood%2FTissue+Analysis+for+Cancer+Biomarker+Discovery%3A+Application+to+Renal+Cell+Carcinoma&amp;rft.au=Blonder%2C+Josip&amp;rft.au=Chan%2C+King+C.&amp;rft.aufirst=Donald+J.&amp;rft.au=Issaq%2C+Haleem+J.&amp;rft.au=Johann%2C+Donald+J.&amp;rft.aulast=Johann&amp;rft.au=Linehan%2C+W.+Marston&amp;rft.au=Prieto%2C+Darue+A.&amp;rft.au=Rudnick%2C+Paul+A.&amp;rft.au=Simpson%2C+R.+Mark&amp;rft.au=Stein%2C+Stephen+E.&amp;rft.au=Valera%2C+Vladimir+A.&amp;rft.au=Veenstra%2C+Timothy+D.&amp;rft.au=Wei%2C+Bih-Rong&amp;rft.au=Xiao%2C+Zhen&amp;rft.au=Ye%2C+Xiaying&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3251958&amp;rft_id=info%3Adoi%2F10.1021%2Fac902204k&amp;rft_id=info%3Apmc%2F3251958&amp;rft_id=info%3Apmid%2F20121140&amp;rft.issue=5&amp;rft.jtitle=Analytical+Chemistry&amp;rft.pages=1584-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=82" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Hatzaras, Ioannis; Gleisner, Ana L.; Pulitano, Carlo; Sandroussi, Charbel; Hirose, Kenzo; Hyder, Omar; Wolfgang, Christopher L.; Aldrighetti, Luca; Crawford, Michael; Choti, Michael A.; Pawlik, Timothy M. (2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3406350">"A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer"</a>. <i>HPB</i> <b>14</b> (8): 532–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1477-2574.2012.00495.x">10.1111/j.1477-2574.2012.00495.x</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3406350">3406350</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22762401">22762401</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=A+multi-institution+analysis+of+outcomes+of+liver-directed+surgery+for+metastatic+renal+cell+cancer&amp;rft.au=Aldrighetti%2C+Luca&amp;rft.au=Choti%2C+Michael+A.&amp;rft.au=Crawford%2C+Michael&amp;rft.aufirst=Ioannis&amp;rft.au=Gleisner%2C+Ana+L.&amp;rft.au=Hatzaras%2C+Ioannis&amp;rft.au=Hirose%2C+Kenzo&amp;rft.au=Hyder%2C+Omar&amp;rft.aulast=Hatzaras&amp;rft.au=Pawlik%2C+Timothy+M.&amp;rft.au=Pulitano%2C+Carlo&amp;rft.au=Sandroussi%2C+Charbel&amp;rft.au=Wolfgang%2C+Christopher+L.&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3406350&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1477-2574.2012.00495.x&amp;rft_id=info%3Apmc%2F3406350&amp;rft_id=info%3Apmid%2F22762401&amp;rft.issue=8&amp;rft.jtitle=HPB&amp;rft.pages=532-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Motzer-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-Motzer_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Motzer, RJ (Apr 1, 2003). "Renal cell carcinoma: a priority malignancy for development and study of novel therapies". <i>Journal of clinical oncology&#160;: official journal of the American Society of Clinical Oncology</i> <b>21</b> (7): 1193–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2003.12.072">10.1200/JCO.2003.12.072</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12663704">12663704</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma%3A+a+priority+malignancy+for+development+and+study+of+novel+therapies&amp;rft.aufirst=RJ&amp;rft.aulast=Motzer&amp;rft.au=Motzer%2C+RJ&amp;rft.date=Apr+1%2C+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2003.12.072&amp;rft_id=info%3Apmid%2F12663704&amp;rft.issue=7&amp;rft.jtitle=Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology&amp;rft.pages=1193-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Sahni, V.A. (1 January 2009). "REVIEW: Biopsy of renal masses: when and why". <i>Cancer Imaging</i> <b>9</b> (1): 44–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1102%2F1470-7330.2009.0005">10.1102/1470-7330.2009.0005</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=REVIEW%3A+Biopsy+of+renal+masses%3A+when+and+why&amp;rft.aufirst=V.A.&amp;rft.aulast=Sahni&amp;rft.au=Sahni%2C+V.A.&amp;rft.date=1+January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1102%2F1470-7330.2009.0005&amp;rft.issue=1&amp;rft.jtitle=Cancer+Imaging&amp;rft.pages=44-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nakada-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nakada_39-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nakada, G; Machida, T; Masuda, F; Onishi, T; Yamazaki, H; Kiyota, H; Suzuki, M; Goto, H (1983). "A case of arteriovenous fistulae secondary to renal cell carcinoma accompanied by congestive heart failure". <i>Hinyokika kiyo. Acta urologica Japonica</i> <b>29</b> (8): 901–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/6675440">6675440</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=A+case+of+arteriovenous+fistulae+secondary+to+renal+cell+carcinoma+accompanied+by+congestive+heart+failure&amp;rft.aufirst=G&amp;rft.au=Goto%2C+H&amp;rft.au=Kiyota%2C+H&amp;rft.aulast=Nakada&amp;rft.au=Machida%2C+T&amp;rft.au=Masuda%2C+F&amp;rft.au=Nakada%2C+G&amp;rft.au=Onishi%2C+T&amp;rft.au=Suzuki%2C+M&amp;rft.au=Yamazaki%2C+H&amp;rft.date=1983&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F6675440&amp;rft.issue=8&amp;rft.jtitle=Hinyokika+kiyo.+Acta+urologica+Japonica&amp;rft.pages=901-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pattamapaspong-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pattamapaspong_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pattamapaspong, Nuttaya; Muttarak, Malai; Sivasomboon, Chate (2011). "Tuberculosis Arthritis and Tenosynovitis". <i>Seminars in Musculoskeletal Radiology</i> <b>15</b> (5): 459–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-0031-1293492">10.1055/s-0031-1293492</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22081281">22081281</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Tuberculosis+Arthritis+and+Tenosynovitis&amp;rft.aufirst=Nuttaya&amp;rft.aulast=Pattamapaspong&amp;rft.au=Muttarak%2C+Malai&amp;rft.au=Pattamapaspong%2C+Nuttaya&amp;rft.au=Sivasomboon%2C+Chate&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0031-1293492&amp;rft_id=info%3Apmid%2F22081281&amp;rft.issue=5&amp;rft.jtitle=Seminars+in+Musculoskeletal+Radiology&amp;rft.pages=459-69&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Israel-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-Israel_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Israel, Gary M.; Bosniak, Morton A. (2005). "How I Do It: Evaluating Renal Masses1". <i>Radiology</i> <b>236</b> (2): 441–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1148%2Fradiol.2362040218">10.1148/radiol.2362040218</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16040900">16040900</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=How+I+Do+It%3A+Evaluating+Renal+Masses1&amp;rft.au=Bosniak%2C+Morton+A.&amp;rft.aufirst=Gary+M.&amp;rft.au=Israel%2C+Gary+M.&amp;rft.aulast=Israel&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1148%2Fradiol.2362040218&amp;rft_id=info%3Apmid%2F16040900&amp;rft.issue=2&amp;rft.jtitle=Radiology&amp;rft.pages=441-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=236" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jubelirer-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jubelirer_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jubelirer_42-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Jubelirer, SJ; Rubin, M (1993). "The use of modern radiologic methods in identifying incidental renal cell carcinoma". <i>The West Virginia medical journal</i> <b>89</b> (1): 21–3. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8421912">8421912</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=The+use+of+modern+radiologic+methods+in+identifying+incidental+renal+cell+carcinoma&amp;rft.aufirst=SJ&amp;rft.au=Jubelirer%2C+SJ&amp;rft.aulast=Jubelirer&amp;rft.au=Rubin%2C+M&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8421912&amp;rft.issue=1&amp;rft.jtitle=The+West+Virginia+medical+journal&amp;rft.pages=21-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Beck-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-Beck_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Beck_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Beck, AD (Oct 1997). "Renal cell carcinoma involving the inferior vena cava: radiologic evaluation and surgical management". <i>The Journal of Urology</i> <b>118</b> (4): 533–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/916043">916043</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma+involving+the+inferior+vena+cava%3A+radiologic+evaluation+and+surgical+management&amp;rft.au=Beck%2C+AD&amp;rft.aufirst=AD&amp;rft.aulast=Beck&amp;rft.date=Oct+1997&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F916043&amp;rft.issue=4&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=533-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sauk-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sauk_44-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sauk, Steven C.; Hsu, Margaret S.; Margolis, Daniel J. A.; Lu, David S. K.; Rao, Nagesh P.; Belldegrun, Arie S.; Pantuck, Allan J.; Raman, Steven S. (2011). "Clear Cell Renal Cell Carcinoma: Multiphasic Multidetector CT Imaging Features Help Predict Genetic Karyotypes". <i>Radiology</i> <b>261</b> (3): 854–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1148%2Fradiol.11101508">10.1148/radiol.11101508</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22025734">22025734</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Clear+Cell+Renal+Cell+Carcinoma%3A+Multiphasic+Multidetector+CT+Imaging+Features+Help+Predict+Genetic+Karyotypes&amp;rft.au=Belldegrun%2C+Arie+S.&amp;rft.aufirst=Steven+C.&amp;rft.au=Hsu%2C+Margaret+S.&amp;rft.aulast=Sauk&amp;rft.au=Lu%2C+David+S.+K.&amp;rft.au=Margolis%2C+Daniel+J.+A.&amp;rft.au=Pantuck%2C+Allan+J.&amp;rft.au=Raman%2C+Steven+S.&amp;rft.au=Rao%2C+Nagesh+P.&amp;rft.au=Sauk%2C+Steven+C.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1148%2Fradiol.11101508&amp;rft_id=info%3Apmid%2F22025734&amp;rft.issue=3&amp;rft.jtitle=Radiology&amp;rft.pages=854-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=261" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hricak-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hricak_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hricak, H; Demas, BE; Williams, RD; McNamara, MT; Hedgcock, MW; Amparo, EG; Tanagho, EA (1985). "Magnetic resonance imaging in the diagnosis and staging of renal and perirenal neoplasms". <i>Radiology</i> <b>154</b> (3): 709–15. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1148%2Fradiology.154.3.3969475">10.1148/radiology.154.3.3969475</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3969475">3969475</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Magnetic+resonance+imaging+in+the+diagnosis+and+staging+of+renal+and+perirenal+neoplasms&amp;rft.au=Amparo%2C+EG&amp;rft.au=Demas%2C+BE&amp;rft.aufirst=H&amp;rft.au=Hedgcock%2C+MW&amp;rft.au=Hricak%2C+H&amp;rft.aulast=Hricak&amp;rft.au=McNamara%2C+MT&amp;rft.au=Tanagho%2C+EA&amp;rft.au=Williams%2C+RD&amp;rft.date=1985&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1148%2Fradiology.154.3.3969475&amp;rft_id=info%3Apmid%2F3969475&amp;rft.issue=3&amp;rft.jtitle=Radiology&amp;rft.pages=709-15&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=154" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Janus-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-Janus_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Janus, CL; Mendelson, DS (1991). "Comparison of MRI and CT for study of renal and perirenal masses". <i>Critical reviews in diagnostic imaging</i> <b>32</b> (2): 69–118. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1863349">1863349</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Comparison+of+MRI+and+CT+for+study+of+renal+and+perirenal+masses&amp;rft.aufirst=CL&amp;rft.au=Janus%2C+CL&amp;rft.aulast=Janus&amp;rft.au=Mendelson%2C+DS&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1863349&amp;rft.issue=2&amp;rft.jtitle=Critical+reviews+in+diagnostic+imaging&amp;rft.pages=69-118&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nishimura-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nishimura_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nishimura, Kazuo; Hida, Shuichi; Okada, Kenichiro; Yoshida, Osamu; Nishimuara, Kazumasa (1988). "Staging and differential diagnosis of renal cell carcinoma: A comparison of magnetic resonance imaging (MRI) and computed tomography (CT)". <i>Acta Urologica Japonica</i> <b>34</b> (8): 1323–31. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3195400">3195400</a>. <a href="/wiki/Handle_System" title="Handle System">hdl</a>:<a rel="nofollow" class="external text" href="http://hdl.handle.net/2433%2F119684">2433/119684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Staging+and+differential+diagnosis+of+renal+cell+carcinoma%3A+A+comparison+of+magnetic+resonance+imaging+%28MRI%29+and+computed+tomography+%28CT%29&amp;rft.aufirst=Kazuo&amp;rft.au=Hida%2C+Shuichi&amp;rft.aulast=Nishimura&amp;rft.au=Nishimuara%2C+Kazumasa&amp;rft.au=Nishimura%2C+Kazuo&amp;rft.au=Okada%2C+Kenichiro&amp;rft.au=Yoshida%2C+Osamu&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3195400&amp;rft.issue=8&amp;rft.jtitle=Acta+Urologica+Japonica&amp;rft.pages=1323-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Reznek-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-Reznek_48-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Reznek, RH (Feb 14, 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1435344">"CT/MRI in staging renal cell carcinoma"</a>. <i>Cancer imaging&#160;: the official publication of the International Cancer Imaging Society</i>. 4 Spec No A (Spec No A): S25–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1102%2F1470-7330.2004.0012">10.1102/1470-7330.2004.0012</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1435344">1435344</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18215972">18215972</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=CT%2FMRI+in+staging+renal+cell+carcinoma&amp;rft.aufirst=RH&amp;rft.aulast=Reznek&amp;rft.au=Reznek%2C+RH&amp;rft.date=Feb+14%2C+2004&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1435344&amp;rft_id=info%3Adoi%2F10.1102%2F1470-7330.2004.0012&amp;rft_id=info%3Apmc%2F1435344&amp;rft_id=info%3Apmid%2F18215972&amp;rft.issue=Spec+No+A&amp;rft.jtitle=Cancer+imaging+%3A+the+official+publication+of+the+International+Cancer+Imaging+Society&amp;rft.pages=S25-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4+Spec+No+A" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kocak-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kocak_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kocak, Mehmet; Sudakoff, Gary S.; Erickson, Scott; Begun, Frank; Datta, Milton (2001). "Using MR Angiography for Surgical Planning in Pelvic Kidney Renal Cell Carcinoma". <i>American Journal of Roentgenology</i> <b>177</b> (3): 659–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2214%2Fajr.177.3.1770659">10.2214/ajr.177.3.1770659</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11517066">11517066</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Using+MR+Angiography+for+Surgical+Planning+in+Pelvic+Kidney+Renal+Cell+Carcinoma&amp;rft.au=Begun%2C+Frank&amp;rft.au=Datta%2C+Milton&amp;rft.au=Erickson%2C+Scott&amp;rft.aufirst=Mehmet&amp;rft.au=Kocak%2C+Mehmet&amp;rft.aulast=Kocak&amp;rft.au=Sudakoff%2C+Gary+S.&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2214%2Fajr.177.3.1770659&amp;rft_id=info%3Apmid%2F11517066&amp;rft.issue=3&amp;rft.jtitle=American+Journal+of+Roentgenology&amp;rft.pages=659-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=177" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-cornellurology-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-cornellurology_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-cornellurology_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cornellurology.com/kidney/gi/rcc.shtml">Kidney Cancer / General Information</a> at Weill Cornell Medical College, James Buchanan Brady Foundation, Department of Urology</span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Oto, A; Herts, B R; Remer, E M; Novick, A C (1998). "Inferior vena cava tumor thrombus in renal cell carcinoma: Staging by MR imaging and impact on surgical treatment". <i>American Journal of Roentgenology</i> <b>171</b> (6): 1619–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2214%2Fajr.171.6.9843299">10.2214/ajr.171.6.9843299</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9843299">9843299</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Inferior+vena+cava+tumor+thrombus+in+renal+cell+carcinoma%3A+Staging+by+MR+imaging+and+impact+on+surgical+treatment&amp;rft.aufirst=A&amp;rft.au=Herts%2C+B+R&amp;rft.aulast=Oto&amp;rft.au=Novick%2C+A+C&amp;rft.au=Oto%2C+A&amp;rft.au=Remer%2C+E+M&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2214%2Fajr.171.6.9843299&amp;rft_id=info%3Apmid%2F9843299&amp;rft.issue=6&amp;rft.jtitle=American+Journal+of+Roentgenology&amp;rft.pages=1619-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=171" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Brit-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Brit_52-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.britannica.com/EBchecked/topic/497921/renal-carcinoma">"Clear-cell Carcinoma, Hypernephroid Tumour, or Hypernephroma"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-03-31</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.btitle=Clear-cell+Carcinoma%2C+Hypernephroid+Tumour%2C+or+Hypernephroma&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.britannica.com%2FEBchecked%2Ftopic%2F497921%2Frenal-carcinoma&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Vasileva-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Vasileva_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vasil'Eva, NN; Koriakina, RF (1976). "Morphological diagnosis of renal cell carcinoma. Histo-cytological parallels". <i>Arkhiv patologii</i> <b>38</b> (12): 12–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1016084">1016084</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Morphological+diagnosis+of+renal+cell+carcinoma.+Histo-cytological+parallels&amp;rft.aufirst=NN&amp;rft.au=Koriakina%2C+RF&amp;rft.aulast=Vasil%27Eva&amp;rft.au=Vasil%27Eva%2C+NN&amp;rft.date=1976&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1016084&amp;rft.issue=12&amp;rft.jtitle=Arkhiv+patologii&amp;rft.pages=12-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-title-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-title_54-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.pathologyatlas.ro/renal-cell-carcinoma-grawitz-tumor-kidney-pathology.php">"Renal clear cell carcinoma (Grawitz tumor)"</a>. <i>Atlas of Pathology</i>. January 30, 2009.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+clear+cell+carcinoma+%28Grawitz+tumor%29&amp;rft.date=January+30%2C+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.pathologyatlas.ro%2Frenal-cell-carcinoma-grawitz-tumor-kidney-pathology.php&amp;rft.jtitle=Atlas+of+Pathology&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lopez-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lopez_55-0">^</a></b></span> <span class="reference-text"><span class="citation journal">López, JI (Mar 2013). "Renal tumors with clear cells. A review". <i>Pathology, research and practice</i> <b>209</b> (3): 137–46. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.prp.2013.01.007">10.1016/j.prp.2013.01.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23433880">23433880</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+tumors+with+clear+cells.+A+review&amp;rft.aufirst=JI&amp;rft.aulast=L%C3%B3pez&amp;rft.au=L%C3%B3pez%2C+JI&amp;rft.date=Mar+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prp.2013.01.007&amp;rft_id=info%3Apmid%2F23433880&amp;rft.issue=3&amp;rft.jtitle=Pathology%2C+research+and+practice&amp;rft.pages=137-46&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=209" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rioux-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rioux_56-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rioux-Leclercq, Nathalie (November 2006). "Le grade nucléaire de fuhrman, facteur pronostique du cancer du rein depuis 25 ans" [The Fuhrman grading system for kidney cancer prognosis]. <i>Progrès en urologie</i> (in French) <b>16</b> (4): 5–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17183964">17183964</a>. <a href="/wiki/Institut_de_l%27information_scientifique_et_technique" title="Institut de l'information scientifique et technique">INIST</a>:<a rel="nofollow" class="external text" href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=18271804">18271804</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Le+grade+nucl%C3%A9aire+de+fuhrman%2C+facteur+pronostique+du+cancer+du+rein+depuis+25+ans&amp;rft.aufirst=Nathalie&amp;rft.aulast=Rioux-Leclercq&amp;rft.au=Rioux-Leclercq%2C+Nathalie&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F17183964&amp;rft.issue=4&amp;rft.jtitle=Progr%C3%A8s+en+urologie&amp;rft.pages=5-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Delahunt-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-Delahunt_57-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Delahunt, Brett; Sika-Paotonu, Dianne; Bethwaite, Peter B.; McCredie, Margaret R. E.; Martignoni, Guido; Eble, John N.; Jordan, T. (2007). "Fuhrman Grading is not Appropriate for Chromophobe Renal Cell Carcinoma". <i>The American Journal of Surgical Pathology</i> <b>31</b> (6): 957–60. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.pas.0000249446.28713.53">10.1097/01.pas.0000249446.28713.53</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17527087">17527087</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Fuhrman+Grading+is+not+Appropriate+for+Chromophobe+Renal+Cell+Carcinoma&amp;rft.au=Bethwaite%2C+Peter+B.&amp;rft.au=Delahunt%2C+Brett&amp;rft.au=Eble%2C+John+N.&amp;rft.aufirst=Brett&amp;rft.au=Jordan%2C+T.&amp;rft.aulast=Delahunt&amp;rft.au=Martignoni%2C+Guido&amp;rft.au=McCredie%2C+Margaret+R.+E.&amp;rft.au=Sika-Paotonu%2C+Dianne&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.pas.0000249446.28713.53&amp;rft_id=info%3Apmid%2F17527087&amp;rft.issue=6&amp;rft.jtitle=The+American+Journal+of+Surgical+Pathology&amp;rft.pages=957-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kovacs-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kovacs_58-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kovacs, Gyula; Akhtar, Mohammed; Beckwith, Bruce J.; Bugert, Peter; Cooper, Colin S.; Delahunt, Brett; Eble, John N.; Fleming, Stewart; Ljungberg, Börje; Medeiros, L. Jeffrey; Moch, Holger; Reuter, Victor E.; Ritz, Eberhard; Roos, Göran; Schmidt, Dietmar; Srigley, John R.; Störkel, Stephan; Van Den Berg, Eva; Zbar, Bert (1997). "The Heidelberg classification of renal cell tumours". <i>The Journal of Pathology</i> <b>183</b> (2): 131–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C131%3A%3AAID-PATH931%3E3.0.CO%3B2-G">10.1002/(SICI)1096-9896(199710)183:2&lt;131::AID-PATH931&gt;3.0.CO;2-G</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9390023">9390023</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=The+Heidelberg+classification+of+renal+cell+tumours&amp;rft.au=Akhtar%2C+Mohammed&amp;rft.au=Beckwith%2C+Bruce+J.&amp;rft.au=Bugert%2C+Peter&amp;rft.au=Cooper%2C+Colin+S.&amp;rft.au=Delahunt%2C+Brett&amp;rft.au=Eble%2C+John+N.&amp;rft.aufirst=Gyula&amp;rft.au=Fleming%2C+Stewart&amp;rft.au=Kovacs%2C+Gyula&amp;rft.aulast=Kovacs&amp;rft.au=Ljungberg%2C+B%C3%B6rje&amp;rft.au=Medeiros%2C+L.+Jeffrey&amp;rft.au=Moch%2C+Holger&amp;rft.au=Reuter%2C+Victor+E.&amp;rft.au=Ritz%2C+Eberhard&amp;rft.au=Roos%2C+G%C3%B6ran&amp;rft.au=Schmidt%2C+Dietmar&amp;rft.au=Srigley%2C+John+R.&amp;rft.au=St%C3%B6rkel%2C+Stephan&amp;rft.au=Van+Den+Berg%2C+Eva&amp;rft.au=Zbar%2C+Bert&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291096-9896%28199710%29183%3A2%3C131%3A%3AAID-PATH931%3E3.0.CO%3B2-G&amp;rft_id=info%3Apmid%2F9390023&amp;rft.issue=2&amp;rft.jtitle=The+Journal+of+Pathology&amp;rft.pages=131-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=183" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-simmons-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-simmons_59-0">^</a></b></span> <span class="reference-text"><span class="citation book">Simmons; Campbell. "Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumours". <i>Renal Cell Carcinoma Clinical Management</i>. Humana Pr Inc. pp.&#160;105–118. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Assessment+of+Oncologic+Risk+for+Clinical+Stage+T1+Renal+Tumours&amp;rft.au=Campbell&amp;rft.aulast=Simmons&amp;rft.au=Simmons&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management.&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=105-118&amp;rft.pub=Humana+Pr+Inc&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-smaldone-60"><span class="mw-cite-backlink">^ <a href="#cite_ref-smaldone_60-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-smaldone_60-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Smaldone, Marc C.; Canter, Daniel; Kutikov, Alexander; Uzzo, Robert G. (2013). "Active Surveillance of the Small Renal Mass". <i>Renal Cell Carcinoma</i>. pp.&#160;167–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2F978-1-62703-062-5_10">10.1007/978-1-62703-062-5_10</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Active+Surveillance+of+the+Small+Renal+Mass&amp;rft.au=Canter%2C+Daniel&amp;rft.aufirst=Marc+C.&amp;rft.au=Kutikov%2C+Alexander&amp;rft.aulast=Smaldone&amp;rft.au=Smaldone%2C+Marc+C.&amp;rft.au=Uzzo%2C+Robert+G.&amp;rft.btitle=Renal+Cell+Carcinoma&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-62703-062-5_10&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=167-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-casey-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-casey_61-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Casey, R.G.; Raheem, O.A.; Elmusharaf, E.; Madhavan, P.; Tolan, M.; Lynch, T.H. (2013). "Renal cell carcinoma with IVC and atrial thrombus: A single centre's 10 year surgical experience". <i>The Surgeon</i> <b>11</b> (6): 295–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.surge.2013.02.007">10.1016/j.surge.2013.02.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23510704">23510704</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma+with+IVC+and+atrial+thrombus%3A+A+single+centre%27s+10+year+surgical+experience&amp;rft.au=Casey%2C+R.G.&amp;rft.au=Elmusharaf%2C+E.&amp;rft.aufirst=R.G.&amp;rft.aulast=Casey&amp;rft.au=Lynch%2C+T.H.&amp;rft.au=Madhavan%2C+P.&amp;rft.au=Raheem%2C+O.A.&amp;rft.au=Tolan%2C+M.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.surge.2013.02.007&amp;rft_id=info%3Apmid%2F23510704&amp;rft.issue=6&amp;rft.jtitle=The+Surgeon&amp;rft.pages=295-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pn_vs_rn_weight-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-pn_vs_rn_weight_62-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Weight, Christopher J.; Larson, Benjamin T.; Fergany, Amr F.; Gao, Tianming; Lane, Brian R.; Campbell, Steven C.; Kaouk, Jihad H.; Klein, Eric A.; Novick, Andrew C. (2010). "Nephrectomy Induced Chronic Renal Insufficiency is Associated with Increased Risk of Cardiovascular Death and Death from Any Cause in Patients with Localized cT1b Renal Masses". <i>The Journal of Urology</i> <b>183</b> (4): 1317–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2009.12.030">10.1016/j.juro.2009.12.030</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20171688">20171688</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Nephrectomy+Induced+Chronic+Renal+Insufficiency+is+Associated+with+Increased+Risk+of+Cardiovascular+Death+and+Death+from+Any+Cause+in+Patients+with+Localized+cT1b+Renal+Masses&amp;rft.au=Campbell%2C+Steven+C.&amp;rft.au=Fergany%2C+Amr+F.&amp;rft.aufirst=Christopher+J.&amp;rft.au=Gao%2C+Tianming&amp;rft.au=Kaouk%2C+Jihad+H.&amp;rft.au=Klein%2C+Eric+A.&amp;rft.au=Lane%2C+Brian+R.&amp;rft.au=Larson%2C+Benjamin+T.&amp;rft.aulast=Weight&amp;rft.au=Novick%2C+Andrew+C.&amp;rft.au=Weight%2C+Christopher+J.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2009.12.030&amp;rft_id=info%3Apmid%2F20171688&amp;rft.issue=4&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=1317-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=183" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-cw_bjui-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-cw_bjui_63-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Weight, Christopher J.; Crispen, Paul L.; Breau, Rodney H.; Kim, Simon P.; Lohse, Christine M.; Boorjian, Stephen A.; Thompson, R. Houston; Leibovich, Bradley C. (2013). "Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons". <i>BJU International</i> <b>111</b> (5): 731–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1464-410X.2012.11112.x">10.1111/j.1464-410X.2012.11112.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22502641">22502641</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Practice-setting+and+surgeon+characteristics+heavily+influence+the+decision+to+perform+partial+nephrectomy+among+American+Urologic+Association+surgeons&amp;rft.au=Boorjian%2C+Stephen+A.&amp;rft.au=Breau%2C+Rodney+H.&amp;rft.au=Crispen%2C+Paul+L.&amp;rft.aufirst=Christopher+J.&amp;rft.au=Kim%2C+Simon+P.&amp;rft.aulast=Weight&amp;rft.au=Leibovich%2C+Bradley+C.&amp;rft.au=Lohse%2C+Christine+M.&amp;rft.au=Thompson%2C+R.+Houston&amp;rft.au=Weight%2C+Christopher+J.&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2012.11112.x&amp;rft_id=info%3Apmid%2F22502641&amp;rft.issue=5&amp;rft.jtitle=BJU+International&amp;rft.pages=731-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Russo2013-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-Russo2013_64-0">^</a></b></span> <span class="reference-text"><span class="citation book">Russo (2013). "Radical Nephrectomy for Localised Renal Tumours: Oncological and Renal Functional Considerations". <i>Renal Cell Carcinoma Clinical Management</i>. Humana Pr Inc. pp.&#160;119–132. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Radical+Nephrectomy+for+Localised+Renal+Tumours%3A+Oncological+and+Renal+Functional+Considerations&amp;rft.aulast=Russo&amp;rft.au=Russo&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management.&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=119-132&amp;rft.pub=Humana+Pr+Inc&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Matin2013-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-Matin2013_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Matin2013_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Matin2013_65-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Matin2013_65-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Matin; Ahrar (2013). "Thermal Ablation". <i>Renal Cell Carcinoma Clinical Management</i>. Humana. pp.&#160;155–166. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Thermal+Ablation&amp;rft.au=Ahrar&amp;rft.aulast=Matin&amp;rft.au=Matin&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=155-166&amp;rft.pub=Humana&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-davar-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-davar_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-davar_66-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-davar_66-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Davar; Fenton; Appleman (2013). "Immunotherapy for Renal Cell Carcinoma". <i>Renal Cell Carcinoma Clinical Management</i>. Humana. pp.&#160;279–302. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Immunotherapy+for+Renal+Cell+Carcinoma&amp;rft.au=Appleman&amp;rft.au=Davar&amp;rft.au=Fenton&amp;rft.aulast=Davar&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management.&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=279-302&amp;rft.pub=Humana&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Santoni, M; De Tursi, M; Felici, A; Lo Re, G; Ricotta, R; Ruggeri, EM; Sabbatini, R; Santini, D; Vaccaro, V; Milella, M (June 2013). "Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.". <i>Expert Review of Anticancer Therapy</i> <b>13</b> (6): 697–709. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1586%2Fera.13.52">10.1586/era.13.52</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23773104">23773104</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Management+of+metastatic+renal+cell+carcinoma+patients+with+poor-risk+features%3A+current+status+and+future+perspectives.&amp;rft.au=De+Tursi%2C+M&amp;rft.au=Felici%2C+A&amp;rft.aufirst=M&amp;rft.aulast=Santoni&amp;rft.au=Lo+Re%2C+G&amp;rft.au=Milella%2C+M&amp;rft.au=Ricotta%2C+R&amp;rft.au=Ruggeri%2C+EM&amp;rft.au=Sabbatini%2C+R&amp;rft.au=Santini%2C+D&amp;rft.au=Santoni%2C+M&amp;rft.au=Vaccaro%2C+V&amp;rft.date=June+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2Fera.13.52&amp;rft_id=info%3Apmid%2F23773104&amp;rft.issue=6&amp;rft.jtitle=Expert+Review+of+Anticancer+Therapy&amp;rft.pages=697-709&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-stroup-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-stroup_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-stroup_68-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Stroup (2013). "Neoadjuvant Targeted Therapy and Consolidative Surgery". <i>Renal Cell Carcinoma Clinical Management</i>. Humana. pp.&#160;219–230. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Neoadjuvant+Targeted+Therapy+and+Consolidative+Surgery&amp;rft.aulast=Stroup&amp;rft.au=Stroup&amp;rft.btitle=Renal+Cell+Carcinoma+Clinical+Management.&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=219-230&amp;rft.pub=Humana&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Shoji, S; Nakano, M; Sato, H; Tang, XY; Osamura, YR; Terachi, T; Uchida, T; Takeya, K (January 2014). "The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.". <i>Clinical &amp; Experimental Metastasis</i> <b>31</b> (1): 111–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs10585-013-9612-7">10.1007/s10585-013-9612-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23959576">23959576</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=The+current+status+of+tailor-made+medicine+with+molecular+biomarkers+for+patients+with+clear+cell+renal+cell+carcinoma.&amp;rft.aufirst=S&amp;rft.aulast=Shoji&amp;rft.au=Nakano%2C+M&amp;rft.au=Osamura%2C+YR&amp;rft.au=Sato%2C+H&amp;rft.au=Shoji%2C+S&amp;rft.au=Takeya%2C+K&amp;rft.au=Tang%2C+XY&amp;rft.au=Terachi%2C+T&amp;rft.au=Uchida%2C+T&amp;rft.date=January+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs10585-013-9612-7&amp;rft_id=info%3Apmid%2F23959576&amp;rft.issue=1&amp;rft.jtitle=Clinical+%26+Experimental+Metastasis&amp;rft.pages=111-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Jonasch, E; Futreal, PA; Davis, IJ; Bailey, ST; Kim, WY; Brugarolas, J; Giaccia, AJ; Kurban, G; Pause, A; Frydman, J; Zurita, AJ; Rini, BI; Sharma, P; Atkins, MB; Walker, CL; Rathmell, WK (July 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3399969">"State of the science: an update on renal cell carcinoma."</a> <span style="font-size:85%;">(PDF)</span>. <i>Molecular Cancer Research</i> <b>10</b> (7): 859–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1541-7786.MCR-12-0117">10.1158/1541-7786.MCR-12-0117</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3399969">3399969</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22638109">22638109</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=State+of+the+science%3A+an+update+on+renal+cell+carcinoma.&amp;rft.au=Atkins%2C+MB&amp;rft.au=Bailey%2C+ST&amp;rft.au=Brugarolas%2C+J&amp;rft.au=Davis%2C+IJ&amp;rft.aufirst=E&amp;rft.au=Frydman%2C+J&amp;rft.au=Futreal%2C+PA&amp;rft.au=Giaccia%2C+AJ&amp;rft.au=Jonasch%2C+E&amp;rft.au=Kim%2C+WY&amp;rft.au=Kurban%2C+G&amp;rft.aulast=Jonasch&amp;rft.au=Pause%2C+A&amp;rft.au=Rathmell%2C+WK&amp;rft.au=Rini%2C+BI&amp;rft.au=Sharma%2C+P&amp;rft.au=Walker%2C+CL&amp;rft.au=Zurita%2C+AJ&amp;rft.date=July+2012&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3399969&amp;rft_id=info%3Adoi%2F10.1158%2F1541-7786.MCR-12-0117&amp;rft_id=info%3Apmc%2F3399969&amp;rft_id=info%3Apmid%2F22638109&amp;rft.issue=7&amp;rft.jtitle=Molecular+Cancer+Research&amp;rft.pages=859-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><span class="citation journal">Dranitsaris, G; Schmitz, S; Broom, RJ (November 2013). "Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy.". <i>Journal of Cancer Research and Clinical Oncology</i> <b>139</b> (11): 1917–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00432-013-1510-5">10.1007/s00432-013-1510-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24037486">24037486</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Small+molecule+targeted+therapies+for+the+second-line+treatment+for+metastatic+renal+cell+carcinoma%3A+a+systematic+review+and+indirect+comparison+of+safety+and+efficacy.&amp;rft.au=Broom%2C+RJ&amp;rft.au=Dranitsaris%2C+G&amp;rft.aufirst=G&amp;rft.aulast=Dranitsaris&amp;rft.au=Schmitz%2C+S&amp;rft.date=November+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00432-013-1510-5&amp;rft_id=info%3Apmid%2F24037486&amp;rft.issue=11&amp;rft.jtitle=Journal+of+Cancer+Research+and+Clinical+Oncology&amp;rft.pages=1917-26&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-nejm-72"><span class="mw-cite-backlink">^ <a href="#cite_ref-nejm_72-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-nejm_72-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-nejm_72-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-nejm_72-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Cohen, Herbert T.; McGovern, Francis J. (2005). "Renal-Cell Carcinoma". <i>New England Journal of Medicine</i> <b>353</b> (23): 2477–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra043172">10.1056/NEJMra043172</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16339096">16339096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal-Cell+Carcinoma&amp;rft.au=Cohen%2C+Herbert+T.&amp;rft.aufirst=Herbert+T.&amp;rft.aulast=Cohen&amp;rft.au=McGovern%2C+Francis+J.&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra043172&amp;rft_id=info%3Apmid%2F16339096&amp;rft.issue=23&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.pages=2477-90&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=353" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DoisMissing-73"><span class="mw-cite-backlink">^ <a href="#cite_ref-DoisMissing_73-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DoisMissing_73-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lam, John S.; Leppert, John T.; Belldegrun, Arie S.; Figlin, Robert A. (2005). "Novel approaches in the therapy of metastatic renal cell carcinoma". <i>World Journal of Urology</i> <b>23</b> (3): 202–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00345-004-0466-0">10.1007/s00345-004-0466-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15812574">15812574</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Novel+approaches+in+the+therapy+of+metastatic+renal+cell+carcinoma&amp;rft.au=Belldegrun%2C+Arie+S.&amp;rft.au=Figlin%2C+Robert+A.&amp;rft.aufirst=John+S.&amp;rft.au=Lam%2C+John+S.&amp;rft.aulast=Lam&amp;rft.au=Leppert%2C+John+T.&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00345-004-0466-0&amp;rft_id=info%3Apmid%2F15812574&amp;rft.issue=3&amp;rft.jtitle=World+Journal+of+Urology&amp;rft.pages=202-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><span class="citation journal">Ljungberg, Börje; Hanbury, Damian C.; Kuczyk, Marcus A.; Merseburger, Axel S.; Mulders, Peter F.A.; Patard, Jean-Jacques; Sinescu, Ioanel C.; European Association of Urology Guideline Group for renal cell carcinoma (2007). "Renal Cell Carcinoma Guideline". <i>European Urology</i> <b>51</b> (6): 1502–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.eururo.2007.03.035">10.1016/j.eururo.2007.03.035</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17408850">17408850</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+Cell+Carcinoma+Guideline&amp;rft.au=European+Association+of+Urology+Guideline+Group+for+renal+cell+carcinoma&amp;rft.aufirst=B%C3%B6rje&amp;rft.au=Hanbury%2C+Damian+C.&amp;rft.au=Kuczyk%2C+Marcus+A.&amp;rft.aulast=Ljungberg&amp;rft.au=Ljungberg%2C+B%C3%B6rje&amp;rft.au=Merseburger%2C+Axel+S.&amp;rft.au=Mulders%2C+Peter+F.A.&amp;rft.au=Patard%2C+Jean-Jacques&amp;rft.au=Sinescu%2C+Ioanel+C.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.eururo.2007.03.035&amp;rft_id=info%3Apmid%2F17408850&amp;rft.issue=6&amp;rft.jtitle=European+Urology&amp;rft.pages=1502-10&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=51" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DoictrvMissing-75"><span class="mw-cite-backlink">^ <a href="#cite_ref-DoictrvMissing_75-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DoictrvMissing_75-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gupta, Kiran; Miller, Jeffrey D.; Li, Jim Z.; Russell, Mason W.; Charbonneau, Claudie (2008). "Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review". <i>Cancer Treatment Reviews</i> <b>34</b> (3): 193–205. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ctrv.2007.12.001">10.1016/j.ctrv.2007.12.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18313224">18313224</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Epidemiologic+and+socioeconomic+burden+of+metastatic+renal+cell+carcinoma+%28mRCC%29%3A+A+literature+review&amp;rft.au=Charbonneau%2C+Claudie&amp;rft.aufirst=Kiran&amp;rft.au=Gupta%2C+Kiran&amp;rft.aulast=Gupta&amp;rft.au=Li%2C+Jim+Z.&amp;rft.au=Miller%2C+Jeffrey+D.&amp;rft.au=Russell%2C+Mason+W.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2007.12.001&amp;rft_id=info%3Apmid%2F18313224&amp;rft.issue=3&amp;rft.jtitle=Cancer+Treatment+Reviews&amp;rft.pages=193-205&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DoiCADbeecMissing-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-DoiCADbeecMissing_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DoiCADbeecMissing_76-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-DoiCADbeecMissing_76-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Buti, Sebastiano; Bersanelli, Melissa; Sikokis, Angelica; Maines, Francesca; Facchinetti, Francesco; Bria, Emilio; Ardizzoni, Andrea; Tortora, Giampaolo; Massari, Francesco (2013). "Chemotherapy in metastatic renal cell carcinoma today? A systematic review". <i>Anti-Cancer Drugs</i>: 1. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FCAD.0b013e3283609ec1">10.1097/CAD.0b013e3283609ec1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Chemotherapy+in+metastatic+renal+cell+carcinoma+today%3F+A+systematic+review&amp;rft.au=Ardizzoni%2C+Andrea&amp;rft.au=Bersanelli%2C+Melissa&amp;rft.au=Bria%2C+Emilio&amp;rft.au=Buti%2C+Sebastiano&amp;rft.au=Facchinetti%2C+Francesco&amp;rft.aufirst=Sebastiano&amp;rft.aulast=Buti&amp;rft.au=Maines%2C+Francesca&amp;rft.au=Massari%2C+Francesco&amp;rft.au=Sikokis%2C+Angelica&amp;rft.au=Tortora%2C+Giampaolo&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FCAD.0b013e3283609ec1&amp;rft.jtitle=Anti-Cancer+Drugs&amp;rft.pages=1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation journal">Patil, Sujata; Manola, Judith; Elson, Paul; Negrier, Sylvie; Escudier, Bernard; Eisen, Tim; Atkins, Michael; Bukowski, Ronald; Motzer, Robert J. (2012). "Improvement in Overall Survival of Patients with Advanced Renal Cell Carcinoma: Prognostic Factor Trend Analysis from an International Data Set of Clinical Trials". <i>The Journal of Urology</i> <b>188</b> (6): 2095–100. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.juro.2012.08.026">10.1016/j.juro.2012.08.026</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23083849">23083849</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Improvement+in+Overall+Survival+of+Patients+with+Advanced+Renal+Cell+Carcinoma%3A+Prognostic+Factor+Trend+Analysis+from+an+International+Data+Set+of+Clinical+Trials&amp;rft.au=Atkins%2C+Michael&amp;rft.au=Bukowski%2C+Ronald&amp;rft.au=Eisen%2C+Tim&amp;rft.au=Elson%2C+Paul&amp;rft.au=Escudier%2C+Bernard&amp;rft.aufirst=Sujata&amp;rft.aulast=Patil&amp;rft.au=Manola%2C+Judith&amp;rft.au=Motzer%2C+Robert+J.&amp;rft.au=Negrier%2C+Sylvie&amp;rft.au=Patil%2C+Sujata&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.juro.2012.08.026&amp;rft_id=info%3Apmid%2F23083849&amp;rft.issue=6&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=2095-100&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=188" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><span class="citation journal">Calvo, Emiliano; Ravaud, Alain; Bellmunt, Joaquim (2013). "What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?". <i>Cancer Treatment Reviews</i> <b>39</b> (4): 366–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ctrv.2012.06.010">10.1016/j.ctrv.2012.06.010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22832091">22832091</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=What+is+the+optimal+therapy+for+patients+with+metastatic+renal+cell+carcinoma+who+progress+on+an+initial+VEGFr-TKI%3F&amp;rft.au=Bellmunt%2C+Joaquim&amp;rft.au=Calvo%2C+Emiliano&amp;rft.aufirst=Emiliano&amp;rft.aulast=Calvo&amp;rft.au=Ravaud%2C+Alain&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2012.06.010&amp;rft_id=info%3Apmid%2F22832091&amp;rft.issue=4&amp;rft.jtitle=Cancer+Treatment+Reviews&amp;rft.pages=366-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><span class="citation journal">Alasker, Ahmed; Meskawi, Malek; Sun, Maxine; Ismail, Salima; Hanna, Nawar; Hansen, Jens; Tian, Zhe; Bianchi, Marco; Perrotte, Paul; Karakiewicz, Pierre I. (2013). "A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma". <i>Cancer Treatment Reviews</i> <b>39</b> (4): 388–401. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.ctrv.2012.12.006">10.1016/j.ctrv.2012.12.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23317510">23317510</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=A+contemporary+update+on+rates+and+management+of+toxicities+of+targeted+therapies+for+metastatic+renal+cell+carcinoma&amp;rft.au=Alasker%2C+Ahmed&amp;rft.au=Bianchi%2C+Marco&amp;rft.aufirst=Ahmed&amp;rft.au=Hanna%2C+Nawar&amp;rft.au=Hansen%2C+Jens&amp;rft.au=Ismail%2C+Salima&amp;rft.au=Karakiewicz%2C+Pierre+I.&amp;rft.aulast=Alasker&amp;rft.au=Meskawi%2C+Malek&amp;rft.au=Perrotte%2C+Paul&amp;rft.au=Sun%2C+Maxine&amp;rft.au=Tian%2C+Zhe&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2012.12.006&amp;rft_id=info%3Apmid%2F23317510&amp;rft.issue=4&amp;rft.jtitle=Cancer+Treatment+Reviews&amp;rft.pages=388-401&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=39" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Motzer1-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-Motzer1_80-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Motzer, R. J.; Bacik, J; Schwartz, LH; Reuter, V; Russo, P; Marion, S; Mazumdar, M (2003). "Prognostic Factors for Survival in Previously Treated Patients with Metastatic Renal Cell Carcinoma". <i>Journal of Clinical Oncology</i> <b>22</b> (3): 454–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1200%2FJCO.2004.06.132">10.1200/JCO.2004.06.132</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14752067">14752067</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Prognostic+Factors+for+Survival+in+Previously+Treated+Patients+with+Metastatic+Renal+Cell+Carcinoma&amp;rft.au=Bacik%2C+J&amp;rft.aufirst=R.+J.&amp;rft.aulast=Motzer&amp;rft.au=Marion%2C+S&amp;rft.au=Mazumdar%2C+M&amp;rft.au=Motzer%2C+R.+J.&amp;rft.au=Reuter%2C+V&amp;rft.au=Russo%2C+P&amp;rft.au=Schwartz%2C+LH&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2004.06.132&amp;rft_id=info%3Apmid%2F14752067&amp;rft.issue=3&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.pages=454-63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Motzer2-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-Motzer2_81-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Motzer, RJ; Mazumdar, M; Bacik, J; Berg, W; Amsterdam, A; Ferrara, J (1999). "Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma". <i>Journal of clinical oncology&#160;: official journal of the American Society of Clinical Oncology</i> <b>17</b> (8): 2530–40. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10561319">10561319</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Survival+and+prognostic+stratification+of+670+patients+with+advanced+renal+cell+carcinoma&amp;rft.au=Amsterdam%2C+A&amp;rft.au=Bacik%2C+J&amp;rft.au=Berg%2C+W&amp;rft.au=Ferrara%2C+J&amp;rft.aufirst=RJ&amp;rft.aulast=Motzer&amp;rft.au=Mazumdar%2C+M&amp;rft.au=Motzer%2C+RJ&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F10561319&amp;rft.issue=8&amp;rft.jtitle=Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology&amp;rft.pages=2530-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Leibovich-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-Leibovich_82-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Leibovich, Bradley C.; Blute, Michael L.; Cheville, John C.; Lohse, Christine M.; Frank, Igor; Kwon, Eugene D.; Weaver, Amy L.; Parker, Alexander S.; Zincke, Horst (2003). "Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma". <i>Cancer</i> <b>97</b> (7): 1663–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.11234">10.1002/cncr.11234</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12655523">12655523</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Prediction+of+progression+after+radical+nephrectomy+for+patients+with+clear+cell+renal+cell+carcinoma&amp;rft.au=Blute%2C+Michael+L.&amp;rft.au=Cheville%2C+John+C.&amp;rft.aufirst=Bradley+C.&amp;rft.au=Frank%2C+Igor&amp;rft.au=Kwon%2C+Eugene+D.&amp;rft.aulast=Leibovich&amp;rft.au=Leibovich%2C+Bradley+C.&amp;rft.au=Lohse%2C+Christine+M.&amp;rft.au=Parker%2C+Alexander+S.&amp;rft.au=Weaver%2C+Amy+L.&amp;rft.au=Zincke%2C+Horst&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.11234&amp;rft_id=info%3Apmid%2F12655523&amp;rft.issue=7&amp;rft.jtitle=Cancer&amp;rft.pages=1663-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Oosterwijk-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-Oosterwijk_83-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Oosterwijk-Wakka, Jeannette C.; Kats-Ugurlu, Gürsah; Leenders, William P.J.; Kiemeney, Lambertus A.L.M.; Old, Lloyd J.; Mulders, Peter F.A.; Oosterwijk, Egbert (2011). "Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250". <i>BJU International</i> <b>107</b> (1): 118–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1464-410X.2010.09314.x">10.1111/j.1464-410X.2010.09314.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20346054">20346054</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Effect+of+tyrosine+kinase+inhibitor+treatment+of+renal+cell+carcinoma+on+the+accumulation+of+carbonic+anhydrase+IX-specific+chimeric+monoclonal+antibody+cG250&amp;rft.aufirst=Jeannette+C.&amp;rft.au=Kats-Ugurlu%2C+G%C3%BCrsah&amp;rft.au=Kiemeney%2C+Lambertus+A.L.M.&amp;rft.aulast=Oosterwijk-Wakka&amp;rft.au=Leenders%2C+William+P.J.&amp;rft.au=Mulders%2C+Peter+F.A.&amp;rft.au=Old%2C+Lloyd+J.&amp;rft.au=Oosterwijk%2C+Egbert&amp;rft.au=Oosterwijk-Wakka%2C+Jeannette+C.&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2010.09314.x&amp;rft_id=info%3Apmid%2F20346054&amp;rft.issue=1&amp;rft.jtitle=BJU+International&amp;rft.pages=118-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=107" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation book">Birkhäuser, Frédéric D.; Kroeger, Nils; Pantuck, Allan J. (2013). "Etiology of Renal Cell Carcinoma: Incidence, Demographics, and Environmental Factors". <i>Renal Cell Carcinoma</i>. pp.&#160;3–22. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2F978-1-62703-062-5_1">10.1007/978-1-62703-062-5_1</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-62703-061-8" title="Special:BookSources/978-1-62703-061-8">978-1-62703-061-8</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Etiology+of+Renal+Cell+Carcinoma%3A+Incidence%2C+Demographics%2C+and+Environmental+Factors&amp;rft.au=Birkh%C3%A4user%2C+Fr%C3%A9d%C3%A9ric+D.&amp;rft.aufirst=Fr%C3%A9d%C3%A9ric+D.&amp;rft.au=Kroeger%2C+Nils&amp;rft.aulast=Birkh%C3%A4user&amp;rft.au=Pantuck%2C+Allan+J.&amp;rft.btitle=Renal+Cell+Carcinoma&amp;rft.date=2013&amp;rft.genre=bookitem&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-62703-062-5_1&amp;rft.isbn=978-1-62703-061-8&amp;rft.pages=3-22&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-history-85"><span class="mw-cite-backlink">^ <a href="#cite_ref-history_85-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-history_85-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-history_85-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-history_85-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-history_85-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Delahunt, Brett (March 8, 2009). <a rel="nofollow" class="external text" href="http://www.uscap.org/site~/98th/pdf/companion09h02.pdf">"History of Renal Neoplasia"</a> <span style="font-size:85%;">(PDF)</span>. <i>United States and Canadian Academy of Pathology 2009 Annual Meeting</i>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=History+of+Renal+Neoplasia&amp;rft.au=Delahunt%2C+Brett&amp;rft.aufirst=Brett&amp;rft.aulast=Delahunt&amp;rft.date=March+8%2C+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.uscap.org%2Fsite~%2F98th%2Fpdf%2Fcompanion09h02.pdf&amp;rft.jtitle=United+States+and+Canadian+Academy+of+Pathology+2009+Annual+Meeting&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;since December 2013">dead link</span></a></i>]</span></sup></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation journal">Delahunt, Brett; Thornton A (1996). "Renal cell carcinoma. A historical perspective". <i>J Urol Pathol</i> <b>4</b>: 31–49.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+cell+carcinoma.+A+historical+perspective&amp;rft.au=Delahunt%2C+Brett&amp;rft.aufirst=Brett&amp;rft.aulast=Delahunt&amp;rft.au=Thornton+A&amp;rft.date=1996&amp;rft.genre=article&amp;rft.jtitle=J+Urol+Pathol&amp;rft.pages=31-49&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation journal">Delahunt, Brett; Eble, John N. (2005). "History of the Development of the Classification of Renal Cell Neoplasia". <i>Clinics in Laboratory Medicine</i> <b>25</b> (2): 231–46, v. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.cll.2005.01.007">10.1016/j.cll.2005.01.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15848734">15848734</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=History+of+the+Development+of+the+Classification+of+Renal+Cell+Neoplasia&amp;rft.au=Delahunt%2C+Brett&amp;rft.au=Eble%2C+John+N.&amp;rft.aufirst=Brett&amp;rft.aulast=Delahunt&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cll.2005.01.007&amp;rft_id=info%3Apmid%2F15848734&amp;rft.issue=2&amp;rft.jtitle=Clinics+in+Laboratory+Medicine&amp;rft.pages=231-46%2C+v&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation journal">Judd, E. Starr (1929). "Carcinoma of the Renal Cortex with Factors Bearing on Prognosis". <i>Archives of Internal Medicine</i> <b>44</b> (5): 746. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinte.1929.00140050123011">10.1001/archinte.1929.00140050123011</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Carcinoma+of+the+Renal+Cortex+with+Factors+Bearing+on+Prognosis&amp;rft.aufirst=E.+Starr&amp;rft.au=Judd%2C+E.+Starr&amp;rft.aulast=Judd&amp;rft.date=1929&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.1929.00140050123011&amp;rft.issue=5&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.pages=746&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><span class="citation journal">Foot, NC; Humphreys, GA; Whitmore, WF (1951). "Renal tumors: Pathology and prognosis in 295 cases". <i>The Journal of Urology</i> <b>66</b> (2): 190–200. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14861941">14861941</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Renal+tumors%3A+Pathology+and+prognosis+in+295+cases&amp;rft.aufirst=NC&amp;rft.au=Foot%2C+NC&amp;rft.au=Humphreys%2C+GA&amp;rft.aulast=Foot&amp;rft.au=Whitmore%2C+WF&amp;rft.date=1951&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F14861941&amp;rft.issue=2&amp;rft.jtitle=The+Journal+of+Urology&amp;rft.pages=190-200&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><span class="citation journal">Oberling, CH.; Rivière, M.; Haguenau, FR. (1960). "Ultrastructure of the Clear Cells in Renal Carcinomas and its Importance for the Demonstration of their Renal Origin". <i>Nature</i> <b>186</b> (4722): 402. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1960Natur.186..402O">1960Natur.186..402O</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F186402a0">10.1038/186402a0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Ultrastructure+of+the+Clear+Cells+in+Renal+Carcinomas+and+its+Importance+for+the+Demonstration+of+their+Renal+Origin&amp;rft.aufirst=CH.&amp;rft.au=Haguenau%2C+FR.&amp;rft.aulast=Oberling&amp;rft.au=Oberling%2C+CH.&amp;rft.au=Rivi%C3%A8re%2C+M.&amp;rft.date=1960&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1960Natur.186..402O&amp;rft_id=info%3Adoi%2F10.1038%2F186402a0&amp;rft.issue=4722&amp;rft.jtitle=Nature&amp;rft.pages=402&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=186" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Valladares2008-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Valladares2008_91-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Valladares Ayerbes, Manuel; Aparicio Gallego, Guadalupe; Díaz Prado, Silvia; Jiménez Fonseca, Paula; García Campelo, Rosario; Antón Aparicio, Luis Miguel (2008). "Origin of renal cell carcinomas". <i>Clinical and Translational Oncology</i> <b>10</b> (11): 697–712. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs12094-008-0276-8">10.1007/s12094-008-0276-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19015066">19015066</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARenal+cell+carcinoma&amp;rft.atitle=Origin+of+renal+cell+carcinomas&amp;rft.au=Ant%C3%B3n+Aparicio%2C+Luis+Miguel&amp;rft.au=Aparicio+Gallego%2C+Guadalupe&amp;rft.au=D%C3%ADaz+Prado%2C+Silvia&amp;rft.aufirst=Manuel&amp;rft.au=Garc%C3%ADa+Campelo%2C+Rosario&amp;rft.au=Jim%C3%A9nez+Fonseca%2C+Paula&amp;rft.aulast=Valladares+Ayerbes&amp;rft.au=Valladares+Ayerbes%2C+Manuel&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs12094-008-0276-8&amp;rft_id=info%3Apmid%2F19015066&amp;rft.issue=11&amp;rft.jtitle=Clinical+and+Translational+Oncology&amp;rft.pages=697-712&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Urologic_neoplasia" title="Template:Urologic neoplasia"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Urologic_neoplasia" title="Template talk:Urologic neoplasia"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Urologic_neoplasia&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Neoplasm" title="Neoplasm">Tumors</a>: <a href="/wiki/Urogenital_neoplasm" title="Urogenital neoplasm">urogenital neoplasia</a>: <a href="/wiki/Urinary_system" title="Urinary system">urinary organs</a> (<a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C64.E2.80.93C68.29_Malignant_neoplasms.2C_urinary_organs" title="ICD-10 Chapter II: Neoplasms">C64–C68/D30</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_genitourinary_organs_.28179.E2.80.93189.29" title="List of ICD-9 codes 140–239: neoplasms">188–189/223</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Abdominal</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Kidney_tumour" title="Kidney tumour">Kidney</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glandular_and_epithelial_neoplasm" title="Glandular and epithelial neoplasm">Glandular and epithelial neoplasm</a>:</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Renal cell carcinoma</strong></li>
<li><a href="/wiki/Renal_oncocytoma" title="Renal oncocytoma">Renal oncocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Complex_and_mixed_tumor" title="Complex and mixed tumor">Complex and mixed tumor</a>:</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Wilms%27_tumor" title="Wilms' tumor">Wilms' tumor</a></li>
<li><a href="/wiki/Mesoblastic_nephroma" title="Mesoblastic nephroma">Mesoblastic nephroma</a></li>
<li><a href="/wiki/Clear-cell_sarcoma_of_the_kidney" title="Clear-cell sarcoma of the kidney">Clear-cell sarcoma of the kidney</a></li>
<li><a href="/wiki/Angiomyolipoma" title="Angiomyolipoma">Angiomyolipoma</a></li>
<li><a href="/wiki/Cystic_nephroma" title="Cystic nephroma">Cystic nephroma</a></li>
<li><a href="/wiki/Metanephric_adenoma" title="Metanephric adenoma">Metanephric adenoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">by location:</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Renal_medullary_carcinoma" title="Renal medullary carcinoma">Renal medullary carcinoma</a></li>
<li><a href="/wiki/Juxtaglomerular_cell_tumor" title="Juxtaglomerular cell tumor">Juxtaglomerular cell tumor</a></li>
<li><a href="/wiki/Renal_medullary_fibroma" title="Renal medullary fibroma">Renal medullary fibroma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Ureteral_cancer" title="Ureteral cancer">Ureter</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ureteral_neoplasm" title="Ureteral neoplasm">Ureteral neoplasm</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Pelvic</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Bladder_cancer" title="Bladder cancer">Bladder</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">Transitional cell carcinoma</a></li>
<li><a href="/wiki/Inverted_papilloma" title="Inverted papilloma">Inverted papilloma</a></li>
<li><a href="/wiki/Squamous-cell_carcinoma#Bladder" title="Squamous-cell carcinoma">Squamous-cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Urethral_cancer" title="Urethral cancer">Urethra</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">Transitional cell carcinoma</a></li>
<li><a href="/wiki/Squamous-cell_carcinoma" title="Squamous-cell carcinoma">Squamous-cell carcinoma</a></li>
<li><a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">Adenocarcinoma</a></li>
<li><a href="/wiki/Melanoma" title="Melanoma">Melanoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Retroperitoneal_space" title="Retroperitoneal space">Retroperitoneum</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pleomorphic_undifferentiated_sarcoma" title="Pleomorphic undifferentiated sarcoma">Malignant fibrous histiocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Urinary_system_navs" title="Template:Urinary system navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Urinary_system_navs" title="Template talk:Urinary system navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Urinary_system_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of the <a href="/wiki/Urinary_system" title="Urinary system">urinary system</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Urinary_system_anatomy" title="Template:Urinary system anatomy">Anatomy</a></li>
<li><a href="/wiki/Template:Renal_physiology" title="Template:Renal physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_urinary_and_reproductive_systems" title="Template:Development of urinary and reproductive systems">Development</a></li>
<li><a href="/wiki/Template:Human_cell_types_derived_primarily_from_mesoderm" title="Template:Human cell types derived primarily from mesoderm">Cells</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Water-electrolyte_imbalance_and_acid-base_imbalance" title="Template:Water-electrolyte imbalance and acid-base imbalance">Electrolyte and acid-base</a></li>
<li><a href="/wiki/Template:Congenital_malformations_of_urinary_system" title="Template:Congenital malformations of urinary system">Congenital</a></li>
<li><a href="/wiki/Template:Urologic_neoplasia" title="Template:Urologic neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Urologic_disease" title="Template:Urologic disease">Other</a></li>
<li><a href="/wiki/Template:Urinary_system_symptoms_and_signs" title="Template:Urinary system symptoms and signs">Symptoms and signs</a></li>
<li><a href="/wiki/Template:Urine_tests" title="Template:Urine tests">Urine tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_urine" title="Template:Abnormal clinical and laboratory findings for urine">findings</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Clinical_biochemistry_blood_tests" title="Template:Clinical biochemistry blood tests">Blood tests</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Urologic_procedures" title="Template:Urologic procedures">Procedures</a></li>
<li><a href="/wiki/Template:Urologicals,_including_antispasmodics" title="Template:Urologicals, including antispasmodics">Drugs</a>
<ul>
<li><a href="/wiki/Template:Drugs_for_treatment_of_hyperkalemia_and_hyperphosphatemia" title="Template:Drugs for treatment of hyperkalemia and hyperphosphatemia">potassium and phosphate</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Intravenous_therapy" title="Template:Intravenous therapy">Intravenous fluids</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Epithelial_neoplasms" title="Template:Epithelial neoplasms"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Epithelial_neoplasms" title="Template talk:Epithelial neoplasms"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Epithelial_neoplasms&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Glandular_and_epithelial_neoplasm" title="Glandular and epithelial neoplasm">Glandular and epithelial</a> <a href="/wiki/Neoplasm" title="Neoplasm">neoplasms</a> (<a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a> 8010-8589)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Epithelium" title="Epithelium">Epithelium</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Papilloma" title="Papilloma">Papilloma</a>/<a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a><br />
(8010-8139)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Small_cell_carcinoma" title="Small cell carcinoma" class="mw-redirect">Small cell carcinoma</a></li>
<li><a href="/wiki/Combined_small-cell_carcinoma" title="Combined small-cell carcinoma" class="mw-redirect">Combined small cell carcinoma</a></li>
<li><a href="/wiki/Verrucous_carcinoma" title="Verrucous carcinoma">Verrucous carcinoma</a></li>
<li><a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma" class="mw-redirect">Squamous cell carcinoma</a></li>
<li><a href="/wiki/Basal_cell_carcinoma" title="Basal cell carcinoma" class="mw-redirect">Basal cell carcinoma</a></li>
<li><a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">Transitional cell carcinoma</a></li>
<li><a href="/wiki/Inverted_papilloma" title="Inverted papilloma">Inverted papilloma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gland" title="Gland">Glands</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Adenoma" title="Adenoma">Adenomas</a>/<br />
<a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinomas</a><br />
(8140-8429)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Digestive_system_neoplasm" title="Digestive system neoplasm">Gastrointestinal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>tract:</i> <a href="/wiki/Linitis_plastica" title="Linitis plastica">Linitis plastica</a></li>
<li><a href="/wiki/Familial_adenomatous_polyposis" title="Familial adenomatous polyposis">Familial adenomatous polyposis</a></li>
</ul>
<ul>
<li><i>pancreas</i>
<ul>
<li><a href="/wiki/Insulinoma" title="Insulinoma">Insulinoma</a></li>
<li><a href="/wiki/Glucagonoma" title="Glucagonoma">Glucagonoma</a></li>
<li><a href="/wiki/Gastrinoma" title="Gastrinoma">Gastrinoma</a></li>
<li><a href="/wiki/VIPoma" title="VIPoma">VIPoma</a></li>
<li><a href="/wiki/Somatostatinoma" title="Somatostatinoma">Somatostatinoma</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Cholangiocarcinoma" title="Cholangiocarcinoma">Cholangiocarcinoma</a></li>
<li><a href="/wiki/Klatskin_tumor" title="Klatskin tumor">Klatskin tumor</a></li>
<li><a href="/wiki/Hepatocellular_adenoma" title="Hepatocellular adenoma">Hepatocellular adenoma</a>/<a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">Hepatocellular carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Urogenital_neoplasm" title="Urogenital neoplasm">Urogenital</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Renal cell carcinoma</strong></li>
<li><a href="/wiki/Endometrioid_tumor" title="Endometrioid tumor">Endometrioid tumor</a></li>
<li><a href="/wiki/Renal_oncocytoma" title="Renal oncocytoma">Renal oncocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Endocrine_gland_neoplasm" title="Endocrine gland neoplasm">Endocrine</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Prolactinoma" title="Prolactinoma">Prolactinoma</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">Multiple endocrine neoplasia</a></li>
<li><a href="/wiki/Adrenocortical_adenoma" title="Adrenocortical adenoma">Adrenocortical adenoma</a>/<a href="/wiki/Adrenocortical_carcinoma" title="Adrenocortical carcinoma">Adrenocortical carcinoma</a></li>
<li><a href="/wiki/Hurthle_cell" title="Hurthle cell">Hurthle cell</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other/multiple</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Neuroendocrine_tumor" title="Neuroendocrine tumor">Neuroendocrine tumor</a>
<ul>
<li><a href="/wiki/Carcinoid" title="Carcinoid">Carcinoid</a></li>
</ul>
</li>
<li><a href="/wiki/Adenoid_cystic_carcinoma" title="Adenoid cystic carcinoma">Adenoid cystic carcinoma</a></li>
<li><a href="/wiki/Oncocytoma" title="Oncocytoma">Oncocytoma</a></li>
<li><a href="/wiki/Clear_cell_adenocarcinoma" title="Clear cell adenocarcinoma" class="mw-redirect">Clear cell adenocarcinoma</a></li>
<li><a href="/wiki/Apudoma" title="Apudoma">Apudoma</a></li>
<li><a href="/wiki/Adenoid_cystic_carcinoma" title="Adenoid cystic carcinoma">Cylindroma</a></li>
<li><a href="/wiki/Papillary_hidradenoma" title="Papillary hidradenoma">Papillary hidradenoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Adnexal_and_skin_appendage_neoplasms" title="Adnexal and skin appendage neoplasms">Adnexal and<br />
skin appendage</a> (8390-8429)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i>sweat gland</i>
<ul>
<li><a href="/wiki/Hidrocystoma" title="Hidrocystoma">Hidrocystoma</a></li>
<li><a href="/wiki/Syringoma" title="Syringoma">Syringoma</a></li>
</ul>
</li>
<li><a href="/wiki/Syringocystadenoma_papilliferum" title="Syringocystadenoma papilliferum">Syringocystadenoma papilliferum</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cystic,_mucinous,_and_serous_neoplasms" title="Cystic, mucinous, and serous neoplasms">Cystic, mucinous,<br />
and serous</a> (8440-8499)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cystic" title="Cystic" class="mw-redirect">Cystic</a> general</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cystadenoma" title="Cystadenoma">Cystadenoma</a>/<a href="/wiki/Cystadenocarcinoma" title="Cystadenocarcinoma">Cystadenocarcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Mucous_gland" title="Mucous gland">Mucinous</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Signet_ring_cell_carcinoma" title="Signet ring cell carcinoma">Signet ring cell carcinoma</a>
<ul>
<li><a href="/wiki/Krukenberg_tumor" title="Krukenberg tumor">Krukenberg tumor</a></li>
</ul>
</li>
<li><span class="wrap"><a href="/wiki/Mucinous_cystadenoma" title="Mucinous cystadenoma">Mucinous cystadenoma</a> / <a href="/wiki/Mucinous_cystadenocarcinoma" title="Mucinous cystadenocarcinoma">Mucinous cystadenocarcinoma</a></span>
<ul>
<li><a href="/wiki/Pseudomyxoma_peritonei" title="Pseudomyxoma peritonei">Pseudomyxoma peritonei</a></li>
</ul>
</li>
<li><a href="/wiki/Mucoepidermoid_carcinoma" title="Mucoepidermoid carcinoma">Mucoepidermoid carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Serous_gland" title="Serous gland">Serous</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><span class="wrap"><a href="/wiki/Ovarian_serous_cystadenoma" title="Ovarian serous cystadenoma">Ovarian serous cystadenoma</a> / <a href="/wiki/Pancreatic_serous_cystadenoma" title="Pancreatic serous cystadenoma">Pancreatic serous cystadenoma</a> / <a href="/wiki/Serous_cystadenocarcinoma" title="Serous cystadenocarcinoma">Serous cystadenocarcinoma</a> / <a href="/wiki/Papillary_serous_cystadenocarcinoma" title="Papillary serous cystadenocarcinoma">Papillary serous cystadenocarcinoma</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Ductal,_lobular,_and_medullary_neoplasms" title="Ductal, lobular, and medullary neoplasms">Ductal, lobular,<br />
and medullary</a> (8500-8549)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Ductal_carcinoma" title="Ductal carcinoma">Ductal carcinoma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mammary_ductal_carcinoma" title="Mammary ductal carcinoma" class="mw-redirect">Mammary ductal carcinoma</a></li>
<li><a href="/wiki/Pancreatic_ductal_carcinoma" title="Pancreatic ductal carcinoma" class="mw-redirect">Pancreatic ductal carcinoma</a></li>
<li><a href="/wiki/Comedocarcinoma" title="Comedocarcinoma">Comedocarcinoma</a></li>
<li><span class="wrap"><a href="/wiki/Paget%27s_disease_of_the_breast" title="Paget's disease of the breast">Paget's disease of the breast</a> / <a href="/wiki/Extramammary_Paget%27s_disease" title="Extramammary Paget's disease">Extramammary Paget's disease</a></span></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lobular_carcinoma" title="Lobular carcinoma">Lobular carcinoma</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lobular_carcinoma_in_situ" title="Lobular carcinoma in situ">Lobular carcinoma in situ</a></li>
<li><a href="/wiki/Invasive_lobular_carcinoma" title="Invasive lobular carcinoma">Invasive lobular carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Medullary_carcinoma" title="Medullary carcinoma">Medullary carcinoma</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Medullary_carcinoma_of_the_breast" title="Medullary carcinoma of the breast">Medullary carcinoma of the breast</a></li>
<li><a href="/wiki/Medullary_thyroid_cancer" title="Medullary thyroid cancer">Medullary thyroid cancer</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Acinus" title="Acinus">Acinar</a> cell (8550-8559)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acinic_cell_carcinoma" title="Acinic cell carcinoma">Acinic cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Complex_and_mixed_tumor" title="Complex and mixed tumor">Complex epithelial</a> (8560-8589)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Warthin%27s_tumor" title="Warthin's tumor">Warthin's tumor</a></li>
<li><a href="/wiki/Thymoma" title="Thymoma">Thymoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<div>
<dl>
<dt>See also</dt>
<dd><a href="/wiki/Template:Epithelium_and_epithelial_tissue" title="Template:Epithelium and epithelial tissue">Template:Epithelium and epithelial tissue</a></dd>
</dl>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1001
CPU time usage: 1.796 seconds
Real time usage: 1.995 seconds
Preprocessor visited node count: 8082/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 308639/2097152 bytes
Template argument size: 2113/2097152 bytes
Highest expansion depth: 12/40
Expensive parser function count: 3/500
Lua time usage: 0.699/10.000 seconds
Lua memory usage: 3.25 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1560.586      1 - -total
 66.18% 1032.722      1 - Template:Reflist
 33.55%  523.574     72 - Template:Cite_journal
 12.69%  198.017     12 - Template:Navbox
  8.14%  126.980      1 - Template:Infobox_disease
  7.13%  111.225      1 - Template:Infobox
  5.55%   86.643     13 - Template:Cite_book
  4.27%   66.580      1 - Template:Dead_link
  3.94%   61.449      1 - Template:Urologic_neoplasia
  3.89%   60.635      1 - Template:Tumor_morphology
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:414178-0!*!0!!en!4!* and timestamp 20150704233325 and revision id 668655105
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Renal_cell_carcinoma&amp;oldid=668655105">https://en.wikipedia.org/w/index.php?title=Renal_cell_carcinoma&amp;oldid=668655105</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Kidney_cancer" title="Category:Kidney cancer">Kidney cancer</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_with_DOIs_inactive_since_2015" title="Category:Pages with DOIs inactive since 2015">Pages with DOIs inactive since 2015</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_December_2013" title="Category:Articles with dead external links from December 2013">Articles with dead external links from December 2013</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Renal+cell+carcinoma&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Renal+cell+carcinoma" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Renal_cell_carcinoma"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Renal_cell_carcinoma"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Renal_cell_carcinoma" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Renal_cell_carcinoma" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Renal_cell_carcinoma" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Renal_cell_carcinoma&amp;oldid=668655105" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Renal_cell_carcinoma&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1164529" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Renal_cell_carcinoma&amp;id=668655105" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Renal+cell+carcinoma">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Renal+cell+carcinoma&amp;oldid=668655105&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Renal_cell_carcinoma&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-be"><a href="//be.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D1%8B%D1%80%D0%BA%D1%96" title="Рак ныркі – Belarusian" lang="be" hreflang="be">Беларуская</a></li><li class="interlanguage-link interwiki-be-x-old"><a href="//be-x-old.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D1%8B%D1%80%D0%BA%D1%96" title="Рак ныркі – беларуская (тарашкевіца)‎" lang="be-x-old" hreflang="be-x-old">Беларуская (тарашкевіца)‎</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Rakovina_ledvin" title="Rakovina ledvin – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Nierenkrebs" title="Nierenkrebs – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Carcinoma_renal" title="Carcinoma renal – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Cancer_du_rein" title="Cancer du rein – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-hy"><a href="//hy.wikipedia.org/wiki/%D4%B5%D6%80%D5%AB%D5%AF%D5%A1%D5%B4%D5%A1%D5%A2%D5%BB%D5%BB%D5%A1%D5%B5%D5%AB%D5%B6_%D6%84%D5%A1%D5%B2%D6%81%D5%AF%D5%A5%D5%B2" title="Երիկամաբջջային քաղցկեղ – Armenian" lang="hy" hreflang="hy">Հայերեն</a></li><li class="interlanguage-link interwiki-hr"><a href="//hr.wikipedia.org/wiki/Rak_bubrega" title="Rak bubrega – Croatian" lang="hr" hreflang="hr">Hrvatski</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Hipernefroma" title="Hipernefroma – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Carcinoma_a_cellule_renali" title="Carcinoma a cellule renali – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Inkst%C5%B3_karcinoma" title="Inkstų karcinoma – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Niercelkanker" title="Niercelkanker – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E8%85%8E%E7%B4%B0%E8%83%9E%E7%99%8C" title="腎細胞癌 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//pl.wikipedia.org/wiki/Rak_nerki" title="Rak nerki – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Carcinoma_de_c%C3%A9lulas_renais" title="Carcinoma de células renais – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BF%D0%BE%D1%87%D0%BA%D0%B8" title="Рак почки – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Renal_cell_carcinoma" title="Renal cell carcinoma – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Munuaissy%C3%B6p%C3%A4" title="Munuaissyöpä – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Njurcellscarcinom" title="Njurcellscarcinom – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A0%D0%B0%D0%BA_%D0%BD%D0%B8%D1%80%D0%BA%D0%B8" title="Рак нирки – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1164529#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 June 2015, at 18:52.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Renal_cell_carcinoma&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":116,"wgHostname":"mw1071"});
}</script>
	</body>
</html>
